winfredcth personal page - To The Moon

winfredcth

winfredcth

No personal profile

263Follow

6Followers

0Topic

0Badge

2021-09-03

Gd to invest now

Sorry, the original content has been removed

2022-02-11

Gd

Block Stock Jumped 6% in Morning Trading after BofA and Citi Buy Rating

2022-09-19

K

Sorry, the original content has been removed

2021-09-03

Gd to know

Sorry, the original content has been removed

2021-08-29

$Apple(AAPL)$#freeappleshare

2021-09-09

Wow..gd to know

Sorry, the original content has been removed

2022-01-04

Cool

3 Wildly Undervalued Stocks to Buy and Hold for the Next Decade

2022-01-25

Ok

3 Money Machine Stocks to Buy at 52-Week Lows

2022-09-13

K

Peloton Shares Plunged over 9% as Chairman Exits in Shake-Up

2022-01-08

Yes

3 COVID Stocks That Will Make Billions in 2022

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"4090372448888540","uuid":"4090372448888540","gmtCreate":1627271224454,"gmtModify":1630203342150,"name":"winfredcth","pinyin":"winfredcth","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/c465570918f25ab6c6a51f818aeceaf0","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":6,"headSize":263,"tweetSize":0,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.09.04","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.09.08","exceedPercentage":"93.68%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.83%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":9955163731,"gmtCreate":1675285439923,"gmtModify":1676538989557,"author":{"id":"4090372448888540","authorId":"4090372448888540","name":"winfredcth","avatar":"https://static.tigerbbs.com/c465570918f25ab6c6a51f818aeceaf0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090372448888540","idStr":"4090372448888540"},"themes":[],"htmlText":"Tq","listText":"Tq","text":"Tq","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9955163731","repostId":"9955371958","repostType":1,"repost":{"id":9955371958,"gmtCreate":1675242443775,"gmtModify":1676538986328,"author":{"id":"4115188532413322","authorId":"4115188532413322","name":"Tiger_Wealth","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4115188532413322","idStr":"4115188532413322"},"themes":[],"title":"Tiger Singapore Weekly Focus: Genting Singapore & Singapore Airline","htmlText":"China’s reopening has a positive effect on the Singapore economy. Some sectors to benefit are hospitality, including tourism operator <a href=\"https://ttm.financial/S/G13.SI\">$GENTING SINGAPORE LIMITED(G13.SI)$</a> and <a href=\"https://ttm.financial/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>.<a href=\"https://ttm.financial/S/G13.SI\">$GENTING SINGAPORE LIMITED(G13.SI)$</a> to benefit from China reopeningGenting Singapore is set to be one of the biggest beneficiaries of Singapore and China’s reopening.Genting Singapore owns and operates Resorts World Sentosa. It operates Universal Studios and a wide range of attractions and amenities around the island. It also operates six themed hotels with about 1,600 hotel rooms, a casino, SEA Aquarium, Adventure Cove Waterpark, and many otherdinings,","listText":"China’s reopening has a positive effect on the Singapore economy. Some sectors to benefit are hospitality, including tourism operator <a href=\"https://ttm.financial/S/G13.SI\">$GENTING SINGAPORE LIMITED(G13.SI)$</a> and <a href=\"https://ttm.financial/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>.<a href=\"https://ttm.financial/S/G13.SI\">$GENTING SINGAPORE LIMITED(G13.SI)$</a> to benefit from China reopeningGenting Singapore is set to be one of the biggest beneficiaries of Singapore and China’s reopening.Genting Singapore owns and operates Resorts World Sentosa. It operates Universal Studios and a wide range of attractions and amenities around the island. It also operates six themed hotels with about 1,600 hotel rooms, a casino, SEA Aquarium, Adventure Cove Waterpark, and many otherdinings,","text":"China’s reopening has a positive effect on the Singapore economy. Some sectors to benefit are hospitality, including tourism operator $GENTING SINGAPORE LIMITED(G13.SI)$ and $SINGAPORE AIRLINES LTD(C6L.SI)$.$GENTING SINGAPORE LIMITED(G13.SI)$ to benefit from China reopeningGenting Singapore is set to be one of the biggest beneficiaries of Singapore and China’s reopening.Genting Singapore owns and operates Resorts World Sentosa. It operates Universal Studios and a wide range of attractions and amenities around the island. It also operates six themed hotels with about 1,600 hotel rooms, a casino, SEA Aquarium, Adventure Cove Waterpark, and many otherdinings,","images":[],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9955371958","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":2,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":3059,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9910820146,"gmtCreate":1663597547986,"gmtModify":1676537298543,"author":{"id":"4090372448888540","authorId":"4090372448888540","name":"winfredcth","avatar":"https://static.tigerbbs.com/c465570918f25ab6c6a51f818aeceaf0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090372448888540","idStr":"4090372448888540"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9910820146","repostId":"1158905038","repostType":4,"repost":{"id":"1158905038","kind":"news","pubTimestamp":1663591588,"share":"https://ttm.financial/m/news/1158905038?lang=en_US&edition=fundamental","pubTime":"2022-09-19 20:46","market":"us","language":"en","title":"QQQ: Summer Glory To Fade Off In Fall Obscurity?","url":"https://stock-news.laohu8.com/highlight/detail?id=1158905038","media":"Seeking Alpha","summary":"SummaryIn this note, we will discuss recent price action in Invesco's QQQ ETF, along with the factor","content":"<html><head></head><body><p>Summary</p><ul><li>In this note, we will discuss recent price action in Invesco&#39;s QQQ ETF, along with the factors driving this action.</li><li>Furthermore, I share a fresh outlook for the QQQ now that my call for a retest of June lows is looking nailed on to materialize.</li><li>I rate QQQ &#39;Neutral&#39; at $290.</li></ul><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/53444cd062deb64dcc2310c4eee26ce0\" tg-width=\"1080\" tg-height=\"637\" referrerpolicy=\"no-referrer\"/><span>Dilok Klaisataporn</span></p><p>Introduction: Where Do We Stand?</p><p>Invesco&#39;s QQQ (NASDAQ:QQQ) is an exchange-traded fund that tracks the tech-heavy Nasdaq-100 index. After a scintillating summer rally off of June lows, tech stocks and equity markets, in general, have resumed their downtrend. The lasttime I wrote on QQQ was back in early June, and here&#39;s what I said at the time:</p><blockquote>In the near term, I see QQQ running up to the $320-330 range, but over the medium term, we are likely to decline to $250-260. These targets are based on fundamental, quantitative, and technical analysis shared in today&#39;s note. With a near-term upside of 3-8% and a medium-term downside of ~20-25%, I&#39;m not too fond of QQQ&#39;s risk/reward here. Therefore, I am neutral on QQQ at current levels.</blockquote><blockquote><i>Source:Is QQQ A Buy Or Sell During The Dip? It&#39;s Complicated</i></blockquote><p>After initially dipping to ~$270 by mid-June, the QQQ went on a smashing rally to reach the $335 level by mid-August. On 15th August 2022, I wrote the following in my newsletter:</p><blockquote>A series of higher highs and higher lows seem to reflect a strong bullish reversal; however, below-average trading volumes are unnerving. We are close to a resistance zone in the $335-345 range, and on the weekly chart, QQQ is testing the top end of the falling wedge pattern we have traded in for the last nine months. A rejection from this zone could quite easily trigger a retest of June lows.</blockquote><blockquote><i>Source:TQI Weekly - Issue #5: A New Bull Market Or Just Another Bear Market Rally</i></blockquote><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/159a6c2ed14077cf70319e8af4b8ccfb\" tg-width=\"640\" tg-height=\"466\" referrerpolicy=\"no-referrer\"/><span>QQQ&#39;s chart as of mid-August (WeBull Desktop)</span></p><p>Now, I am not sharing this history to showcase some extraordinary ability to predict the stock market. Instead, I strongly believe that nobody knows where the market is going in the near term. All we can do is analyze the fundamental, quantitative, and technical data to get a better understanding of what could happen in the market. And then orient our investing operations to benefit from this probabilistic understanding of the market environment.</p><p>Sticky inflation, rising interest rates, hawkish monetary policy, and slowing economic activity do not portend strong equity market returns for the foreseeable future. On Tuesday, the CPI inflation print came in hotter-than-expected at 8.3%, surprising market participants betting on a drop off in inflation. However, on the ground, inflation is slowing down [e.g., prices at the gas station are down significantly in recent weeks, home prices are declining, used auto prices are way off their peak, and there are many other instances]. Now, the lagging rents data (~30-40% of CPI) is set to make the headline inflation numbers look bad for some time to come.</p><p>While renowned investors like Ray Dalio and Jeff Gundlach called out the rising probability of a recession during this week (and predicted another 20-25% decline in S&amp;P500), the Fed seems to be focusing on countering inflation - moving full steam ahead with its quantitative tightening program. The expectations for the Fed&#39;s September meeting (on 21st and 22nd) are now pointing toward a 75-100 bps hike in the federal funds rate, and the bond market seems to be pricing in more hawkishness from Fed chair Jay Powell, as treasury rates continue to shift up rapidly.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b6d4fb12a3da252cd53a6b5e96f4a380\" tg-width=\"640\" tg-height=\"460\" referrerpolicy=\"no-referrer\"/><span>YCharts</span></p><p>Legendary investor Warren Buffett&#39;s quote comes to mind:</p><blockquote>Interest rates are to asset prices what gravity is to the apple. When there are low interest rates, there is a very low gravitational pull on asset prices. The most important item over time in valuation is obviously interest rates.</blockquote><p>As interest rates have shot up in 2022, equities have been getting re-rated lower, and after a 28% YTD decline, the P/E ratio for Invesco&#39;s QQQ ETF (QQQ) [an ETF tracking Nasdaq-100 index] has come down to ~22-23x. Looking at historical data from the past ten years, the QQQ seems like a no-brainer buy at around 20x earnings.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5a4da36ad357f2be93d1e18fbcb5edbc\" tg-width=\"640\" tg-height=\"328\" referrerpolicy=\"no-referrer\"/><span>GuruFocus</span></p><p>However, persistently-high inflation, rising interest rates, and slowing economic activity (amidst waning consumer confidence) are significant threats to corporate earnings and the valuation multiples attached to these earnings. Honestly, earnings may be the next shoe to drop in this market cycle, and Q3 &amp; Q4 could bring a lot more volatility to the equity markets.</p><p>A Look At Some Recent Market Action</p><p>Broad market indices [S&amp;P500 (SPX), Nasdaq-100 (NDX), and Dow Jones Industrial Average (DIA)] got off to a strong start in September; however, volatility returned to Wall Street last week. On Tuesday, stocks took a tumble (SPY down ~4%, QQQ down ~5%) as inflation data came in hotter-than-expected - raising expectations of a 75-100 bps rate hike by the Fed at its September meeting and even more hawkishness from the Fed. After a couple of benign days on Wednesday and Thursday, the sell-off resumed on Friday, with all major indices closing in the red. With the Fed tightening into a slowing economy, the fears of an economic recession are growing.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f0576618c7710bd346a4a0f9d24e86a0\" tg-width=\"640\" tg-height=\"439\" referrerpolicy=\"no-referrer\"/><span>YCharts</span></p><p>At my recently launched marketplace service, The Quantamental Investor, we saw our GARP &amp; Buyback-Dividend portfolios experience a negative ROIC of -1.42% and -1.54% over the last two weeks, with a big chunk of weakness coming from a sell-off in large to mega-cap tech stocks. Interestingly, the performance of small to mid-cap (higher growth) companies was superior to that of their larger counterparts. As of the close on Friday, TQI&#39;s Moonshot Growth portfolio had an ROIC of +3.76%, which was better than iShares Russell 1000 Growth ETF&#39;s (IWF) return of -1.86%.</p><p><img src=\"https://static.tigerbbs.com/8806662e5af57a7b54a1a3e62a249693\" tg-width=\"905\" tg-height=\"264\" referrerpolicy=\"no-referrer\"/></p><p>At TQI, our playbook for this bear market is -</p><blockquote>Build long positions slowly and manage risk proactively.</blockquote><p>If equity prices continue to fall over the coming weeks and months, then our dollar cost averaging plan will prove to be an effective risk management strategy. At TQI, we started our core portfolios with a 50% cash position, which we intend to deploy in a staggered way over the next ten months.</p><p>Where Is The Market Headed Next?</p><p>I don&#39;t know where the market will be a week, a month, or a quarter from now. However, considering valuations and technical charts, I think a retest of QQQ&#39;s June lows of ~$270 is very likely in the near term.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a46914a4f61975720b899626da4c4047\" tg-width=\"640\" tg-height=\"478\" referrerpolicy=\"no-referrer\"/><span>WeBull Desktop</span></p><p>If we fail to hold these levels, QQQ may be in for a decline to the $215-235 range. And I say this because the tech generals (largest components) in QQQ - Apple and Microsoft - have a potential downside of ~30-40% each. Read my latest articles on this subject to understand my reasoning for this call:</p><ul><li>Microsoft: Insider Selling, Frothy Valuation, Worsening Fundamentals, And More [September 15th, 2022]</li><li>Apple Vs. Microsoft Vs. Treasury Bonds: The Battle Of Safe Havens Round-2 [August 25th, 2022]</li><li>Apple Vs. Microsoft Vs. Treasury Bonds: The Battle Of Safe Havens [April 20th, 2022]</li></ul><p>We are getting closer to the Q3 (fall) earnings season, and that&#39;s when we could see a resolution on either side of the ~$270 level. With rising interest rates, the P/E trading multiples on QQQ are unlikely to expand in the foreseeable future (unless the earnings drop off, in which case the price will likely follow). Overall, I am not too fond of QQQ&#39;s medium-term risk-reward from current levels.</p><p>Final Thoughts</p><p>The Fed is hawkish as ever, and its balance sheet roll-off has just started. At some point, the Fed will break something in the economy, and then we will see yet another pivot. However, investors may have to undergo a lot more pain in equity markets before this happens. As the old adage goes -</p><blockquote><b>Don&#39;t Fight The Fed.</b></blockquote><p>And we are abiding by this rule in all of TQI&#39;s core portfolios by running our investing operations with ~50% in cash and deploying this cash slowly in a staggered fashion over a long period of time.</p><p>Over the near term, the QQQ is likely headed to June lows of ~$270, which is a downside of -7%. With the near and medium-term risk/reward being unattractive, I continue to rate QQQ &#39;Neutral&#39; at ~$290.</p><p>While broad market [QQQ] is not enticing, there are loads of individual stocks offering asymmetric risk/reward opportunities. Being selective, contrarian, and right could yield spectacular returns for investors buying during periods of heightened volatility like the one we are experiencing today. I&#39;ll leave you with this thought - &#34;Invest actively and manage risk proactively.&#34;</p><p><b>Key Takeaway:</b> I am neutral on QQQ at current levels.</p><p>Thank you for reading, and happy investing. Please feel free to share any questions, thoughts, or concerns in the comments section below.</p><p><i>This article was written by Ahan Vashi, </i><i>for reference only.</i></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>QQQ: Summer Glory To Fade Off In Fall Obscurity?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQQQ: Summer Glory To Fade Off In Fall Obscurity?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-19 20:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4541722-qqq-summer-glory-fade-off-fall-obscurity><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SummaryIn this note, we will discuss recent price action in Invesco's QQQ ETF, along with the factors driving this action.Furthermore, I share a fresh outlook for the QQQ now that my call for a retest...</p>\n\n<a href=\"https://seekingalpha.com/article/4541722-qqq-summer-glory-fade-off-fall-obscurity\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NDX":"纳斯达克100指数",".IXIC":"NASDAQ Composite","QQQ":"纳指100ETF"},"source_url":"https://seekingalpha.com/article/4541722-qqq-summer-glory-fade-off-fall-obscurity","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158905038","content_text":"SummaryIn this note, we will discuss recent price action in Invesco's QQQ ETF, along with the factors driving this action.Furthermore, I share a fresh outlook for the QQQ now that my call for a retest of June lows is looking nailed on to materialize.I rate QQQ 'Neutral' at $290.Dilok KlaisatapornIntroduction: Where Do We Stand?Invesco's QQQ (NASDAQ:QQQ) is an exchange-traded fund that tracks the tech-heavy Nasdaq-100 index. After a scintillating summer rally off of June lows, tech stocks and equity markets, in general, have resumed their downtrend. The lasttime I wrote on QQQ was back in early June, and here's what I said at the time:In the near term, I see QQQ running up to the $320-330 range, but over the medium term, we are likely to decline to $250-260. These targets are based on fundamental, quantitative, and technical analysis shared in today's note. With a near-term upside of 3-8% and a medium-term downside of ~20-25%, I'm not too fond of QQQ's risk/reward here. Therefore, I am neutral on QQQ at current levels.Source:Is QQQ A Buy Or Sell During The Dip? It's ComplicatedAfter initially dipping to ~$270 by mid-June, the QQQ went on a smashing rally to reach the $335 level by mid-August. On 15th August 2022, I wrote the following in my newsletter:A series of higher highs and higher lows seem to reflect a strong bullish reversal; however, below-average trading volumes are unnerving. We are close to a resistance zone in the $335-345 range, and on the weekly chart, QQQ is testing the top end of the falling wedge pattern we have traded in for the last nine months. A rejection from this zone could quite easily trigger a retest of June lows.Source:TQI Weekly - Issue #5: A New Bull Market Or Just Another Bear Market RallyQQQ's chart as of mid-August (WeBull Desktop)Now, I am not sharing this history to showcase some extraordinary ability to predict the stock market. Instead, I strongly believe that nobody knows where the market is going in the near term. All we can do is analyze the fundamental, quantitative, and technical data to get a better understanding of what could happen in the market. And then orient our investing operations to benefit from this probabilistic understanding of the market environment.Sticky inflation, rising interest rates, hawkish monetary policy, and slowing economic activity do not portend strong equity market returns for the foreseeable future. On Tuesday, the CPI inflation print came in hotter-than-expected at 8.3%, surprising market participants betting on a drop off in inflation. However, on the ground, inflation is slowing down [e.g., prices at the gas station are down significantly in recent weeks, home prices are declining, used auto prices are way off their peak, and there are many other instances]. Now, the lagging rents data (~30-40% of CPI) is set to make the headline inflation numbers look bad for some time to come.While renowned investors like Ray Dalio and Jeff Gundlach called out the rising probability of a recession during this week (and predicted another 20-25% decline in S&P500), the Fed seems to be focusing on countering inflation - moving full steam ahead with its quantitative tightening program. The expectations for the Fed's September meeting (on 21st and 22nd) are now pointing toward a 75-100 bps hike in the federal funds rate, and the bond market seems to be pricing in more hawkishness from Fed chair Jay Powell, as treasury rates continue to shift up rapidly.YChartsLegendary investor Warren Buffett's quote comes to mind:Interest rates are to asset prices what gravity is to the apple. When there are low interest rates, there is a very low gravitational pull on asset prices. The most important item over time in valuation is obviously interest rates.As interest rates have shot up in 2022, equities have been getting re-rated lower, and after a 28% YTD decline, the P/E ratio for Invesco's QQQ ETF (QQQ) [an ETF tracking Nasdaq-100 index] has come down to ~22-23x. Looking at historical data from the past ten years, the QQQ seems like a no-brainer buy at around 20x earnings.GuruFocusHowever, persistently-high inflation, rising interest rates, and slowing economic activity (amidst waning consumer confidence) are significant threats to corporate earnings and the valuation multiples attached to these earnings. Honestly, earnings may be the next shoe to drop in this market cycle, and Q3 & Q4 could bring a lot more volatility to the equity markets.A Look At Some Recent Market ActionBroad market indices [S&P500 (SPX), Nasdaq-100 (NDX), and Dow Jones Industrial Average (DIA)] got off to a strong start in September; however, volatility returned to Wall Street last week. On Tuesday, stocks took a tumble (SPY down ~4%, QQQ down ~5%) as inflation data came in hotter-than-expected - raising expectations of a 75-100 bps rate hike by the Fed at its September meeting and even more hawkishness from the Fed. After a couple of benign days on Wednesday and Thursday, the sell-off resumed on Friday, with all major indices closing in the red. With the Fed tightening into a slowing economy, the fears of an economic recession are growing.YChartsAt my recently launched marketplace service, The Quantamental Investor, we saw our GARP & Buyback-Dividend portfolios experience a negative ROIC of -1.42% and -1.54% over the last two weeks, with a big chunk of weakness coming from a sell-off in large to mega-cap tech stocks. Interestingly, the performance of small to mid-cap (higher growth) companies was superior to that of their larger counterparts. As of the close on Friday, TQI's Moonshot Growth portfolio had an ROIC of +3.76%, which was better than iShares Russell 1000 Growth ETF's (IWF) return of -1.86%.At TQI, our playbook for this bear market is -Build long positions slowly and manage risk proactively.If equity prices continue to fall over the coming weeks and months, then our dollar cost averaging plan will prove to be an effective risk management strategy. At TQI, we started our core portfolios with a 50% cash position, which we intend to deploy in a staggered way over the next ten months.Where Is The Market Headed Next?I don't know where the market will be a week, a month, or a quarter from now. However, considering valuations and technical charts, I think a retest of QQQ's June lows of ~$270 is very likely in the near term.WeBull DesktopIf we fail to hold these levels, QQQ may be in for a decline to the $215-235 range. And I say this because the tech generals (largest components) in QQQ - Apple and Microsoft - have a potential downside of ~30-40% each. Read my latest articles on this subject to understand my reasoning for this call:Microsoft: Insider Selling, Frothy Valuation, Worsening Fundamentals, And More [September 15th, 2022]Apple Vs. Microsoft Vs. Treasury Bonds: The Battle Of Safe Havens Round-2 [August 25th, 2022]Apple Vs. Microsoft Vs. Treasury Bonds: The Battle Of Safe Havens [April 20th, 2022]We are getting closer to the Q3 (fall) earnings season, and that's when we could see a resolution on either side of the ~$270 level. With rising interest rates, the P/E trading multiples on QQQ are unlikely to expand in the foreseeable future (unless the earnings drop off, in which case the price will likely follow). Overall, I am not too fond of QQQ's medium-term risk-reward from current levels.Final ThoughtsThe Fed is hawkish as ever, and its balance sheet roll-off has just started. At some point, the Fed will break something in the economy, and then we will see yet another pivot. However, investors may have to undergo a lot more pain in equity markets before this happens. As the old adage goes -Don't Fight The Fed.And we are abiding by this rule in all of TQI's core portfolios by running our investing operations with ~50% in cash and deploying this cash slowly in a staggered fashion over a long period of time.Over the near term, the QQQ is likely headed to June lows of ~$270, which is a downside of -7%. With the near and medium-term risk/reward being unattractive, I continue to rate QQQ 'Neutral' at ~$290.While broad market [QQQ] is not enticing, there are loads of individual stocks offering asymmetric risk/reward opportunities. Being selective, contrarian, and right could yield spectacular returns for investors buying during periods of heightened volatility like the one we are experiencing today. I'll leave you with this thought - \"Invest actively and manage risk proactively.\"Key Takeaway: I am neutral on QQQ at current levels.Thank you for reading, and happy investing. Please feel free to share any questions, thoughts, or concerns in the comments section below.This article was written by Ahan Vashi, for reference only.","news_type":1,"symbols_score_info":{"QQQ":0.9,".IXIC":0.9,"NDX":0.9}},"isVote":1,"tweetType":1,"viewCount":3411,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9910820316,"gmtCreate":1663597535236,"gmtModify":1676537298543,"author":{"id":"4090372448888540","authorId":"4090372448888540","name":"winfredcth","avatar":"https://static.tigerbbs.com/c465570918f25ab6c6a51f818aeceaf0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090372448888540","idStr":"4090372448888540"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/9910820316","repostId":"1158905038","repostType":4,"isVote":1,"tweetType":1,"viewCount":4011,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9935612814,"gmtCreate":1663080252838,"gmtModify":1676537198776,"author":{"id":"4090372448888540","authorId":"4090372448888540","name":"winfredcth","avatar":"https://static.tigerbbs.com/c465570918f25ab6c6a51f818aeceaf0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090372448888540","idStr":"4090372448888540"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9935612814","repostId":"1127934010","repostType":4,"repost":{"id":"1127934010","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1663078318,"share":"https://ttm.financial/m/news/1127934010?lang=en_US&edition=fundamental","pubTime":"2022-09-13 22:11","market":"us","language":"en","title":"Peloton Shares Plunged over 9% as Chairman Exits in Shake-Up","url":"https://stock-news.laohu8.com/highlight/detail?id=1127934010","media":"Tiger Newspress","summary":"Peloton shares plunged over 9% as chairman exits in shake-up. Peloton co-founder John Foley and othe","content":"<html><head></head><body><p>Peloton shares plunged over 9% as chairman exits in shake-up. Peloton co-founder John Foley and other senior leaders are leaving the company in a management shake-up as the maker of connected exercise equipment races to turn itself around.<img src=\"https://static.tigerbbs.com/59406f646cb326d6b842b73c686354a5\" tg-width=\"830\" tg-height=\"826\" width=\"100%\" height=\"auto\"/>Peloton has struggled with deepening losses this year after a pandemic-fueled spike in demand for its at-home workouts left the company with a glut of unsold bicycles when consumers returned to gyms and outdoor activities. The company’s shares have plunged more than 90% over the past year.</p><p>Mr. Foley, who led the company for most of its 10-year existence,stepped down as CEOin February but remained executive chairman of the board. He resigned on Monday, the company said, and will be succeeded as board chair byKaren Boone, a former executive at Restoration Hardware and a Peloton board member since 2019.</p><p>The shake-up, announced by Chief Executive Barry McCarthy, comes weeks after Peloton reported a $1.2 billion quarterly loss and a nearly 30% drop in revenue. Mr. McCarthywarned investors in Augustthat the business would likely spend more cash than it brings in for several more months.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Peloton Shares Plunged over 9% as Chairman Exits in Shake-Up</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPeloton Shares Plunged over 9% as Chairman Exits in Shake-Up\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-09-13 22:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Peloton shares plunged over 9% as chairman exits in shake-up. Peloton co-founder John Foley and other senior leaders are leaving the company in a management shake-up as the maker of connected exercise equipment races to turn itself around.<img src=\"https://static.tigerbbs.com/59406f646cb326d6b842b73c686354a5\" tg-width=\"830\" tg-height=\"826\" width=\"100%\" height=\"auto\"/>Peloton has struggled with deepening losses this year after a pandemic-fueled spike in demand for its at-home workouts left the company with a glut of unsold bicycles when consumers returned to gyms and outdoor activities. The company’s shares have plunged more than 90% over the past year.</p><p>Mr. Foley, who led the company for most of its 10-year existence,stepped down as CEOin February but remained executive chairman of the board. He resigned on Monday, the company said, and will be succeeded as board chair byKaren Boone, a former executive at Restoration Hardware and a Peloton board member since 2019.</p><p>The shake-up, announced by Chief Executive Barry McCarthy, comes weeks after Peloton reported a $1.2 billion quarterly loss and a nearly 30% drop in revenue. Mr. McCarthywarned investors in Augustthat the business would likely spend more cash than it brings in for several more months.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PTON":"Peloton Interactive, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1127934010","content_text":"Peloton shares plunged over 9% as chairman exits in shake-up. Peloton co-founder John Foley and other senior leaders are leaving the company in a management shake-up as the maker of connected exercise equipment races to turn itself around.Peloton has struggled with deepening losses this year after a pandemic-fueled spike in demand for its at-home workouts left the company with a glut of unsold bicycles when consumers returned to gyms and outdoor activities. The company’s shares have plunged more than 90% over the past year.Mr. Foley, who led the company for most of its 10-year existence,stepped down as CEOin February but remained executive chairman of the board. He resigned on Monday, the company said, and will be succeeded as board chair byKaren Boone, a former executive at Restoration Hardware and a Peloton board member since 2019.The shake-up, announced by Chief Executive Barry McCarthy, comes weeks after Peloton reported a $1.2 billion quarterly loss and a nearly 30% drop in revenue. Mr. McCarthywarned investors in Augustthat the business would likely spend more cash than it brings in for several more months.","news_type":1,"symbols_score_info":{"PTON":0.9}},"isVote":1,"tweetType":1,"viewCount":4077,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9998282684,"gmtCreate":1661006165051,"gmtModify":1676536437981,"author":{"id":"4090372448888540","authorId":"4090372448888540","name":"winfredcth","avatar":"https://static.tigerbbs.com/c465570918f25ab6c6a51f818aeceaf0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090372448888540","idStr":"4090372448888540"},"themes":[],"htmlText":"k","listText":"k","text":"k","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9998282684","repostId":"9991762503","repostType":1,"repost":{"id":9991762503,"gmtCreate":1660881209064,"gmtModify":1677159826393,"author":{"id":"3501196737273098","authorId":"3501196737273098","name":"Tiger_comments","avatar":"https://community-static.tradeup.com/news/227887b200e9925968650d5db4a8bfb3","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3501196737273098","idStr":"3501196737273098"},"themes":[],"title":"How Did 20-Year-Old Student Made $110 Mln In a Month?","htmlText":"A 20-year-old US university student has&nbsp;earned&nbsp;$110m&nbsp;from&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/BBBY\">$Bed Bath &amp; Beyond(BBBY)$</a> .Let's&nbsp;look&nbsp;at&nbsp;how&nbsp;he&nbsp;made&nbsp;it:1.&nbsp;A&nbsp;Legendary Bet On BBBYIn July,&nbsp;Jake Freeman&nbsp;raised the $25m from friends and family&nbsp;and bought&nbsp;5m shares in&nbsp;BBBY&nbsp;at less than $5.50 a share.&nbsp;His uncle helped him establish the&nbsp;Freeman Capital Management fund (FCM),&nbsp;which&nbsp;he&nbsp;used&nbsp;to&nbsp;invest&nbsp;in&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/BBBY\">$Bed Bath &amp; Beyond(BBBY)$</a> .It’s said that&nbsp;Freeman&nbsp;sold all his shares at around $28&nbsp;and&nbsp;earned&nbsp;$110m. He almost sold his share at a high level compared to the c","listText":"A 20-year-old US university student has&nbsp;earned&nbsp;$110m&nbsp;from&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/BBBY\">$Bed Bath &amp; Beyond(BBBY)$</a> .Let's&nbsp;look&nbsp;at&nbsp;how&nbsp;he&nbsp;made&nbsp;it:1.&nbsp;A&nbsp;Legendary Bet On BBBYIn July,&nbsp;Jake Freeman&nbsp;raised the $25m from friends and family&nbsp;and bought&nbsp;5m shares in&nbsp;BBBY&nbsp;at less than $5.50 a share.&nbsp;His uncle helped him establish the&nbsp;Freeman Capital Management fund (FCM),&nbsp;which&nbsp;he&nbsp;used&nbsp;to&nbsp;invest&nbsp;in&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/BBBY\">$Bed Bath &amp; Beyond(BBBY)$</a> .It’s said that&nbsp;Freeman&nbsp;sold all his shares at around $28&nbsp;and&nbsp;earned&nbsp;$110m. He almost sold his share at a high level compared to the c","text":"A 20-year-old US university student has earned $110m from $Bed Bath & Beyond(BBBY)$ .Let's look at how he made it:1. A Legendary Bet On BBBYIn July, Jake Freeman raised the $25m from friends and family and bought 5m shares in BBBY at less than $5.50 a share. His uncle helped him establish the Freeman Capital Management fund (FCM), which he used to invest in $Bed Bath & Beyond(BBBY)$ .It’s said that Freeman sold all his shares at around $28 and earned $110m. He almost sold his share at a high level compared to the c","images":[{"img":"https://community-static.tradeup.com/news/28a52ecf8ae5edd93f1dfff5e17e6b42","width":"1280","height":"675"},{"img":"https://community-static.tradeup.com/news/e2c4b57dfdecd6e05f8a8cc97c0cc86c","width":"675","height":"633"},{"img":"https://community-static.tradeup.com/news/0f49a7f9ddca03db9842c89c395f615c","width":"830","height":"428"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9991762503","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":3,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":3353,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9014575049,"gmtCreate":1649689176542,"gmtModify":1676534551716,"author":{"id":"4090372448888540","authorId":"4090372448888540","name":"winfredcth","avatar":"https://static.tigerbbs.com/c465570918f25ab6c6a51f818aeceaf0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090372448888540","idStr":"4090372448888540"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9014575049","repostId":"2226150380","repostType":2,"isVote":1,"tweetType":1,"viewCount":2972,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9095150066,"gmtCreate":1644854650768,"gmtModify":1676533968650,"author":{"id":"4090372448888540","authorId":"4090372448888540","name":"winfredcth","avatar":"https://static.tigerbbs.com/c465570918f25ab6c6a51f818aeceaf0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090372448888540","idStr":"4090372448888540"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9095150066","repostId":"1150127139","repostType":4,"repost":{"id":"1150127139","kind":"news","pubTimestamp":1644850911,"share":"https://ttm.financial/m/news/1150127139?lang=en_US&edition=fundamental","pubTime":"2022-02-14 23:01","market":"us","language":"en","title":"Apollo Agrees to Buy Novolex From Carlyle for $6 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1150127139","media":"Bloomberg","summary":"(Bloomberg) -- Apollo Global Management Inc. will buy a majority stake in Novolex Holdings from Carl","content":"<html><head></head><body><p>(Bloomberg) -- Apollo Global Management Inc. will buy a majority stake in Novolex Holdings from Carlyle Group Inc.</p><p>Carlyle will retain a minority stake in the packaging company, according to a statement Monday that confirmed an earlier Bloomberg News report. Financial terms were not disclosed.</p><p>The transaction values Novolex at about $6 billion, a person familiar with the matter said, asking not to be identified because the matter isn’t public.</p><p>Novolex develops and manufactures plastic and paper products, including bags, cups and to-go containers, used by the food service industry. Apollo plans to help the company strike more relationships with blue-chip customers, according to the statement.</p><p>The deal is the latest large-scale packaging company to be purchased by private equity, which likes the steady cash flow. Stone Canyon Industries is considering a sale of Mauser Packaging Solutions that could value the company at as much as $8 billion, while the owners of Five Star Holdings are also considering a sale for the company, Bloomberg News has reported.</p><p>Carlyle acquired Novolex in 2016 from Wind Point Partners and TPG Inc.</p><p>The firm, led by Chairman and Chief Executive Officer Stanley Bikulege, employs more than 10,000 people and operates 57 manufacturing facilities worldwide with brands including Hilex Poly, Duro Bag and Burrows Packaging.</p><p>“We are proud of our partnership with Stan and team, who have nearly doubled the size of the company since we first invested in Novolex in 2016,” Wes Bieligk, managing director at Carlyle, said in the statement. “We’re excited to see the company enter its new phase with Apollo and look forward to our continued partnership as a minority investor.”</p><p>Deutsche Bank AG, Evercore Inc., and Barclays Plc advised Apollo on the deal, while Credit Suisse Group AG and Goldman Sachs Group Inc. advised Novolex and Carlyle.</p></body></html>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apollo Agrees to Buy Novolex From Carlyle for $6 Billion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApollo Agrees to Buy Novolex From Carlyle for $6 Billion\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-14 23:01 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/apollo-agrees-buy-novolex-carlyle-143606283.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- Apollo Global Management Inc. will buy a majority stake in Novolex Holdings from Carlyle Group Inc.Carlyle will retain a minority stake in the packaging company, according to a ...</p>\n\n<a href=\"https://finance.yahoo.com/news/apollo-agrees-buy-novolex-carlyle-143606283.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"APO":"阿波罗全球管理"},"source_url":"https://finance.yahoo.com/news/apollo-agrees-buy-novolex-carlyle-143606283.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1150127139","content_text":"(Bloomberg) -- Apollo Global Management Inc. will buy a majority stake in Novolex Holdings from Carlyle Group Inc.Carlyle will retain a minority stake in the packaging company, according to a statement Monday that confirmed an earlier Bloomberg News report. Financial terms were not disclosed.The transaction values Novolex at about $6 billion, a person familiar with the matter said, asking not to be identified because the matter isn’t public.Novolex develops and manufactures plastic and paper products, including bags, cups and to-go containers, used by the food service industry. Apollo plans to help the company strike more relationships with blue-chip customers, according to the statement.The deal is the latest large-scale packaging company to be purchased by private equity, which likes the steady cash flow. Stone Canyon Industries is considering a sale of Mauser Packaging Solutions that could value the company at as much as $8 billion, while the owners of Five Star Holdings are also considering a sale for the company, Bloomberg News has reported.Carlyle acquired Novolex in 2016 from Wind Point Partners and TPG Inc.The firm, led by Chairman and Chief Executive Officer Stanley Bikulege, employs more than 10,000 people and operates 57 manufacturing facilities worldwide with brands including Hilex Poly, Duro Bag and Burrows Packaging.“We are proud of our partnership with Stan and team, who have nearly doubled the size of the company since we first invested in Novolex in 2016,” Wes Bieligk, managing director at Carlyle, said in the statement. “We’re excited to see the company enter its new phase with Apollo and look forward to our continued partnership as a minority investor.”Deutsche Bank AG, Evercore Inc., and Barclays Plc advised Apollo on the deal, while Credit Suisse Group AG and Goldman Sachs Group Inc. advised Novolex and Carlyle.","news_type":1,"symbols_score_info":{"APO":0.9}},"isVote":1,"tweetType":1,"viewCount":3185,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9095127544,"gmtCreate":1644854634365,"gmtModify":1676533968642,"author":{"id":"4090372448888540","authorId":"4090372448888540","name":"winfredcth","avatar":"https://static.tigerbbs.com/c465570918f25ab6c6a51f818aeceaf0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090372448888540","idStr":"4090372448888540"},"themes":[],"htmlText":"Gd","listText":"Gd","text":"Gd","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9095127544","repostId":"1187289492","repostType":4,"repost":{"id":"1187289492","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1644851764,"share":"https://ttm.financial/m/news/1187289492?lang=en_US&edition=fundamental","pubTime":"2022-02-14 23:16","market":"us","language":"en","title":"DiDi Shares Rose Nearly 7% in Morning Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1187289492","media":"Tiger Newspress","summary":"DiDi shares rose nearly 7% in morning trading. The stock once fell 3% in premarket trading.Chinese m","content":"<html><head></head><body><p>DiDi shares rose nearly 7% in morning trading. The stock once fell 3% in premarket trading.<img src=\"https://static.tigerbbs.com/b1409a434873fbaaa85ca382c4d7bafa\" tg-width=\"718\" tg-height=\"608\" referrerpolicy=\"no-referrer\"/>Chinese media outlet LatePost reported on Monday that Didi Global Inc., the Chinese ride-hailing giant, is now implementing the company’s long-rumored layoffs. One Didi employee said that the plan will be implemented very quickly and that layoff notices will be completed by the end of February.</p><p>The proportion of layoffs will vary from department to department. The overall layoff ratio will remain at 20%, and the operations and business departments will be cut by 20%.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DiDi Shares Rose Nearly 7% in Morning Trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDiDi Shares Rose Nearly 7% in Morning Trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-02-14 23:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>DiDi shares rose nearly 7% in morning trading. The stock once fell 3% in premarket trading.<img src=\"https://static.tigerbbs.com/b1409a434873fbaaa85ca382c4d7bafa\" tg-width=\"718\" tg-height=\"608\" referrerpolicy=\"no-referrer\"/>Chinese media outlet LatePost reported on Monday that Didi Global Inc., the Chinese ride-hailing giant, is now implementing the company’s long-rumored layoffs. One Didi employee said that the plan will be implemented very quickly and that layoff notices will be completed by the end of February.</p><p>The proportion of layoffs will vary from department to department. The overall layoff ratio will remain at 20%, and the operations and business departments will be cut by 20%.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DIDI":"滴滴(已退市)"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1187289492","content_text":"DiDi shares rose nearly 7% in morning trading. The stock once fell 3% in premarket trading.Chinese media outlet LatePost reported on Monday that Didi Global Inc., the Chinese ride-hailing giant, is now implementing the company’s long-rumored layoffs. One Didi employee said that the plan will be implemented very quickly and that layoff notices will be completed by the end of February.The proportion of layoffs will vary from department to department. The overall layoff ratio will remain at 20%, and the operations and business departments will be cut by 20%.","news_type":1,"symbols_score_info":{"DIDI":0.9}},"isVote":1,"tweetType":1,"viewCount":2788,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9092845465,"gmtCreate":1644593132918,"gmtModify":1676533944667,"author":{"id":"4090372448888540","authorId":"4090372448888540","name":"winfredcth","avatar":"https://static.tigerbbs.com/c465570918f25ab6c6a51f818aeceaf0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090372448888540","idStr":"4090372448888540"},"themes":[],"htmlText":"Gd","listText":"Gd","text":"Gd","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9092845465","repostId":"1191871987","repostType":4,"repost":{"id":"1191871987","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1644590744,"share":"https://ttm.financial/m/news/1191871987?lang=en_US&edition=fundamental","pubTime":"2022-02-11 22:45","market":"us","language":"en","title":"Block Stock Jumped 6% in Morning Trading after BofA and Citi Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1191871987","media":"Tiger Newspress","summary":"Block stock jumped 6% in morning trading after BofA and Citi Buy ratingBofA analyst Jason Kupferberg","content":"<html><head></head><body><p>Block stock jumped 6% in morning trading after BofA and Citi Buy rating<img src=\"https://static.tigerbbs.com/cbb193c0641f24519c680ade98388335\" tg-width=\"1116\" tg-height=\"764\" referrerpolicy=\"no-referrer\"/>BofA analyst Jason Kupferberg upgraded to Buy from Neutral with a price target of $185.00 per share, down from $221.00. The analyst sees a discount in shares as the market is undervaluing the Cash App value.</p><p>“Following big underperformance in shares of SQ, we conducted a sum-of-the-parts (SOTP) analysis, which suggests the market is currently ascribing only ~$6.5B of value to Cash App, or ~$93 per annual active user vs. PYPL at $326 and AFRM at $1,472. Shares have lagged due to a combination of the general growth sell-off and continued limited visibility on the near-term and medium-term trajectory of Cash App gross profit (GP) growth, where concerns became further heightened following PYPL’s commentary on 2/1/22 regarding weakness in post-stimulus spending among lower-income cohorts. Headlines regarding Apple’s introduction of iPhone-based card acceptance have also weighed on SQ,” Kupferberg said in a client note.</p><p>Citi analyst Peter Christiansen resumed research coverage on Block with a Buy, $220.00 price target.</p><p>“We see the SQ+APT value creation opportunity to be more than just (i) ecosystem integration or (ii) a globalization accelerant – two very powerful rationales nonetheless. For us, we see the combination expanding both the new product development canvas (TAM vectors), as well as Block’s product development capabilities (asset extensions, time-to-market, differentiation),” Christiansen wrote in the report.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Block Stock Jumped 6% in Morning Trading after BofA and Citi Buy Rating</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBlock Stock Jumped 6% in Morning Trading after BofA and Citi Buy Rating\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-02-11 22:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Block stock jumped 6% in morning trading after BofA and Citi Buy rating<img src=\"https://static.tigerbbs.com/cbb193c0641f24519c680ade98388335\" tg-width=\"1116\" tg-height=\"764\" referrerpolicy=\"no-referrer\"/>BofA analyst Jason Kupferberg upgraded to Buy from Neutral with a price target of $185.00 per share, down from $221.00. The analyst sees a discount in shares as the market is undervaluing the Cash App value.</p><p>“Following big underperformance in shares of SQ, we conducted a sum-of-the-parts (SOTP) analysis, which suggests the market is currently ascribing only ~$6.5B of value to Cash App, or ~$93 per annual active user vs. PYPL at $326 and AFRM at $1,472. Shares have lagged due to a combination of the general growth sell-off and continued limited visibility on the near-term and medium-term trajectory of Cash App gross profit (GP) growth, where concerns became further heightened following PYPL’s commentary on 2/1/22 regarding weakness in post-stimulus spending among lower-income cohorts. Headlines regarding Apple’s introduction of iPhone-based card acceptance have also weighed on SQ,” Kupferberg said in a client note.</p><p>Citi analyst Peter Christiansen resumed research coverage on Block with a Buy, $220.00 price target.</p><p>“We see the SQ+APT value creation opportunity to be more than just (i) ecosystem integration or (ii) a globalization accelerant – two very powerful rationales nonetheless. For us, we see the combination expanding both the new product development canvas (TAM vectors), as well as Block’s product development capabilities (asset extensions, time-to-market, differentiation),” Christiansen wrote in the report.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191871987","content_text":"Block stock jumped 6% in morning trading after BofA and Citi Buy ratingBofA analyst Jason Kupferberg upgraded to Buy from Neutral with a price target of $185.00 per share, down from $221.00. The analyst sees a discount in shares as the market is undervaluing the Cash App value.“Following big underperformance in shares of SQ, we conducted a sum-of-the-parts (SOTP) analysis, which suggests the market is currently ascribing only ~$6.5B of value to Cash App, or ~$93 per annual active user vs. PYPL at $326 and AFRM at $1,472. Shares have lagged due to a combination of the general growth sell-off and continued limited visibility on the near-term and medium-term trajectory of Cash App gross profit (GP) growth, where concerns became further heightened following PYPL’s commentary on 2/1/22 regarding weakness in post-stimulus spending among lower-income cohorts. Headlines regarding Apple’s introduction of iPhone-based card acceptance have also weighed on SQ,” Kupferberg said in a client note.Citi analyst Peter Christiansen resumed research coverage on Block with a Buy, $220.00 price target.“We see the SQ+APT value creation opportunity to be more than just (i) ecosystem integration or (ii) a globalization accelerant – two very powerful rationales nonetheless. For us, we see the combination expanding both the new product development canvas (TAM vectors), as well as Block’s product development capabilities (asset extensions, time-to-market, differentiation),” Christiansen wrote in the report.","news_type":1,"symbols_score_info":{"SQ":0.9}},"isVote":1,"tweetType":1,"viewCount":3927,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9096127886,"gmtCreate":1644333962282,"gmtModify":1676533913951,"author":{"id":"4090372448888540","authorId":"4090372448888540","name":"winfredcth","avatar":"https://static.tigerbbs.com/c465570918f25ab6c6a51f818aeceaf0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090372448888540","idStr":"4090372448888540"},"themes":[],"htmlText":"Tq","listText":"Tq","text":"Tq","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9096127886","repostId":"1153281093","repostType":4,"repost":{"id":"1153281093","kind":"news","pubTimestamp":1644333754,"share":"https://ttm.financial/m/news/1153281093?lang=en_US&edition=fundamental","pubTime":"2022-02-08 23:22","market":"us","language":"en","title":"7 Best Blue-Chip Stocks to Buy for Safety in This Volatile Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1153281093","media":"InvestorPlace","summary":"Blue-chip stocks present a unique opportunity in volitile markets, and we volatility seems to be the watchword for the start of the year.The stock market took a hammering in January, which turned out ","content":"<div>\n<p>Blue-chip stocks present a unique opportunity in volitile markets, and we volatility seems to be the watchword for the start of the year.The stock market took a hammering in January, which turned out ...</p>\n\n<a href=\"https://investorplace.com/2022/02/7-best-blue-chip-stocks-to-buy-for-safety-in-this-volatile-market/\">Source Link</a>\n\n</div>\n","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Best Blue-Chip Stocks to Buy for Safety in This Volatile Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Best Blue-Chip Stocks to Buy for Safety in This Volatile Market\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-08 23:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/02/7-best-blue-chip-stocks-to-buy-for-safety-in-this-volatile-market/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Blue-chip stocks present a unique opportunity in volitile markets, and we volatility seems to be the watchword for the start of the year.The stock market took a hammering in January, which turned out ...</p>\n\n<a href=\"https://investorplace.com/2022/02/7-best-blue-chip-stocks-to-buy-for-safety-in-this-volatile-market/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果","COST":"好市多","PFE":"辉瑞","INTC":"英特尔","XOM":"埃克森美孚","WMT":"沃尔玛","LMT":"洛克希德马丁"},"source_url":"https://investorplace.com/2022/02/7-best-blue-chip-stocks-to-buy-for-safety-in-this-volatile-market/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1153281093","content_text":"Blue-chip stocks present a unique opportunity in volitile markets, and we volatility seems to be the watchword for the start of the year.The stock market took a hammering in January, which turned out to be theworst start to the yearin over a decade. The incredible volatility in the market is attributable to multiple macro-economic factors, which have investors scrambling to safe-haven investments. Hence, it’s best to add a few blue-chip stocks to your portfolio to minimize risks.Investors are caught amid a perfect storm in the stock market. The Fed’s hawkish policies, the rising inflation, geopolitical tensions, and the pandemic’s grip over the world have pulverized market returns. Moreover, the Cboe Volatility Index is up over 70% year-to-date.Hence, in the current scenario, it’s best to bet on blue-chip stocks with a long track record of top and bottom-line growth. Additionally, these companies also have strong track records of growing shareholder rewards despite the challenges presented by the market.Let’s now look at seven of the most attractive blue-chip stocks to buy at this time.Apple Walmart Exxon Mobil Pfizer Intel Corporation Costco Wholesale Lockheed Martin Apple Source: dennizn / Shutterstock.comApple has had a phenomenal run in the past couple of years,crossing $3 trillion in market capitalizationlast month.Despite the challenges, AAPL stock has generated solid returns over the past year, driven by staggering growth across all its business segments. The iPhone market boasts a most innovative product lineup with a loyal customer base.The free cash flow juggernaut boasts a levered FCF growth of 20%. Its cash flow expansion rate is stunning and will continue to grow with its top-line. Revenue growth is over 28.5% on a year-over-year basis, comfortably ahead of its 5-year average.Apple has done incredibly well to leverage several secular megatrends, including 5G, the metaverse, streaming, EVs, and whatnot. Hence, if there’s one blue-chip to buy, you’d want to invest in AAPL.Walmart Source: fotomak / Shutterstock.comWalmart has proven time and being that it’s the template for its sector.The retail giant has dominated the brick-and-mortar sector and has significantly expanded its eCommerce wing. Though the pandemic has slightly altered its growth trajectory, its long-term case remains firmly intact.During the first nine months of fiscal 2022, Walmart’s $416 billion sales increased by 3% compared with the prior-year period. However, its net income slid 35%.Nevertheless, it projects optimism and expects a 6% growth in comparable sales for the year. It has also raised earnings guidancefor the year by 20 cents to $6.40 per share.Looking ahead, the company will continue improving its eCommerce productivity and return to winning ways with its brick-and-mortar business.Exxon Mobil Source: Jonathan Weiss / Shutterstock.comExxon Mobil grew its earnings at an astounding pace last year. Year-over-year growth in its EBITDA is at a spectacular 75%.The oil and gas giant also is ramping up capital expenditure to explore a clean energy future and offers an attractive 4.37% dividend yield with remarkable consistency.Exxon Mobil saw a massive improvement in its top-line due to the robust crude oil prices last year. Revenues grew at a rapid clip while it managed to reduce debt levels by a colossal $20 billion.It improved its breakdown significantly by getting a better handle on costs. Additionally, it could spend a truckload of cash on expanding its low carbon efforts.With an impressive asset portfolio, outstanding financials and a tremendous outlook ahead, XOM stock is in a fantastic position to grow for the foreseeable future.Pfizer Source: photobyphm / Shutterstock.comPharmaceutical giant Pfizer has raked in billions from coronavirus vaccines sales, and its vaccines continue to be in high demand with the emergence of new variants of the virus.Vaccine salescontributed $36 billionin sales last year, doubling revenues for the company from 2020.Pfizer has demonstrated superb execution and scaling capacity, making it a top vaccine manufacturer in the west.Moreover, the pandemic is expected to be endemic, and the vaccine maker can still rake in plenty of moolah for the foreseeable future.It is also developing new products such as an oral antiviral tablet to treat early-stage Covid 19 symptoms. Hence, PFE stock still has a strong growth runway ahead.Intel Corporation Intel is one of the most powerful tech giants globally, with a market cap of over $180 billion.It is a household name in the semi-conductor space possessing superior manufacturing capabilities. In recent years, though, it has ceded a considerable amount of market share to its peers.It now looks as if Intel has a clear road to claw back its market share and expand into other profitable verticals.As we advance, the company will be looking to source some of its components from TSMC(NYSE:TSM) in speeding up chip development.It also plans to set up its personal chip foundry service, and its acquisition of autonomousdriving solutions provider Mobileyecould potentially unlock $50 billion in value.Also, Intel has the organic resources to pursue its developments plans, as it continues to generate unbelievable cash flows.Costco Wholesale Source: ARTYOORAN / Shutterstock.comRetail giant Costco has been one of the most consistent performers in its sector.Last year, the company grew its top and bottom lines by double-digits by 17.5% and 25.1%, respectively.With its water-tight balance sheet and unique competitive advantages, COST stock has been one of the top growth stocks over the years.Costco added 22 new warehouses to expand its outreach and more than 6 million new membersto its subscription service, with a roughly 92% renewal rate.Though its membership fees represent a small portion of sales, they contribute immensely to expanding profitability margins.The ability to offer low prices fuels membership growth. Hence, there’s plenty to love about COST stock as a long-term bet.Lockheed Martin Source: Ken Wolter / Shutterstock.comLockheed Martin is the leading defense contractor for the United States government.It has become a juggernaut in the space by being a provider of the F-35 JSF program.The company has been a robust performer with double-digit average revenue growth over the past five years while generating a monstrous 53% return during the same period.Last year,the company delivered 142 F-35 jetsto its customers, beating its previous guidance of 139 deliveries. Moreover, it expects to nail its production goal of 151-153 jets next year. The stellar performance has led to a healthy increase in its FCF margin to 7.3%. On top of that, it’s maintained its reputation as a top income stock in the space, with a 2.9% yield and a payout ratio of over 35%.","news_type":1,"symbols_score_info":{"COST":0.9,"LMT":0.9,"PFE":0.9,"XOM":0.9,"AAPL":0.9,"WMT":0.9,"INTC":0.9}},"isVote":1,"tweetType":1,"viewCount":2867,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9090140518,"gmtCreate":1643125166942,"gmtModify":1676533776521,"author":{"id":"4090372448888540","authorId":"4090372448888540","name":"winfredcth","avatar":"https://static.tigerbbs.com/c465570918f25ab6c6a51f818aeceaf0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090372448888540","idStr":"4090372448888540"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9090140518","repostId":"2206351468","repostType":4,"repost":{"id":"2206351468","kind":"highlight","pubTimestamp":1643123844,"share":"https://ttm.financial/m/news/2206351468?lang=en_US&edition=fundamental","pubTime":"2022-01-25 23:17","market":"us","language":"en","title":"3 Money Machine Stocks to Buy at 52-Week Lows","url":"https://stock-news.laohu8.com/highlight/detail?id=2206351468","media":"Motley Fool","summary":"These fintech businesses are raking in profits, but their stock prices have been tanking anyway.","content":"<div>\n<p>Did you miss out on the mega-dip of March 2020? Well, the market meltdown of early 2022 is giving investors another chance to buy heaps of stocks that once rocketed upwards at a deep discount.Of ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/25/3-money-machine-stocks-to-buy-at-52-week-lows/\">Source Link</a>\n\n</div>\n","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Money Machine Stocks to Buy at 52-Week Lows</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Money Machine Stocks to Buy at 52-Week Lows\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-25 23:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/25/3-money-machine-stocks-to-buy-at-52-week-lows/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Did you miss out on the mega-dip of March 2020? Well, the market meltdown of early 2022 is giving investors another chance to buy heaps of stocks that once rocketed upwards at a deep discount.Of ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/25/3-money-machine-stocks-to-buy-at-52-week-lows/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"COIN":"Coinbase Global, Inc.","BK4532":"文艺复兴科技持仓","BK4503":"景林资产持仓","BK4551":"寇图资本持仓","BK4554":"元宇宙及AR概念","BK4116":"互联网服务与基础架构","BK4566":"资本集团","SHOP":"Shopify Inc","BK4528":"SaaS概念","BK4524":"宅经济概念","BK4112":"金融交易所和数据","BK4539":"次新股","BK4548":"巴美列捷福持仓","BK4106":"数据处理与外包服务","BK4535":"淡马锡持仓"},"source_url":"https://www.fool.com/investing/2022/01/25/3-money-machine-stocks-to-buy-at-52-week-lows/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2206351468","content_text":"Did you miss out on the mega-dip of March 2020? Well, the market meltdown of early 2022 is giving investors another chance to buy heaps of stocks that once rocketed upwards at a deep discount.Of course, not every high-growth stock that fell down this year deserves to get back up, and many won't. Luckily there's an easy way to tell which stocks are most likely to bounce back. They're the ones with cash in the bank and the means to generate lots more.Shares of these three fintech stocks have been beaten down to prices we haven't seen in over a year. That's a little surprising when you consider how much cash they're generating. Here's how patient investors who buy these stocks now could come out miles ahead down the road.1. Coinbase GlobalCoinbase Global (NASDAQ:COIN) stock has lost nearly half its value since reaching a peak last November. Now that the stock is trading near a 52-week low, you can scoop up shares for just 4.3 times the amount of free cash flow generated over the past 12 months.Declining cryptocurrency prices generally translate into significantly less trading activity, but Bitcoin, Ethereum, and an endless array of altcoins aren't going to disappear any time soon. Coinbase Global pockets trading fees that could make a stockbroker blush, so it doesn't take a crypto trading frenzy like we saw last year to drive strong profits.Third-quarter transaction revenue plunged 44% from the previous quarter to $1.1 billion, but premium service subscription revenue jumped 41% to $145 million. Altogether, the company still reported an impressive $618 million in adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA).Coinbase Global is already raking in cash hand over fist as a trading platform for cryptocurrencies themselves. Before the end of the year, though, growth could accelerate with the planned launch of a marketplace for trading non-fungible tokens (NFTs).2. ShopifyNow that the consumer spending boom brought about by the lockdown period of the pandemic has faded, Shopify (NYSE:SHOP) stock has tumbled to a 52-week low. Shares of the e-commerce giant are down by nearly half since the peak they reached last November despite being strongly profitable. Shopify reported an impressive $458 million in free cash flow over the past year.Shopify's recently depressed price looks like a terrific buying opportunity for patient investors. That's because it's going to take a lot more than a temporary consumer trend to stop this cash cow from delivering more profits down the road.At its heart, Shopify helps small business owners compete with their larger rivals. That usually includes helping businesses convert social media engagement into new product sales. Shopify's biggest draw, though, is a giant logistics network that enables much better fulfillment services than Shopify's clients could hope to provide by themselves. Even a sole proprietor just starting out with a new retail business can tap into Shopify's network of warehouses, which is rivaled only by Amazon and a few big box stores.In addition to your cousin's homemade candle shop, Shopify partners with some of the world's most recognizable brands, including Heineken, Logitech, and Hallmark. Making itself an indispensable partner for businesses large and small helped top-line revenue soar 46% year over year in the third quarter to $1.1 billion. With a relatively untapped network of entrepreneurs outside of the U.S. and an important partnership with Global-E Online to bring them into the fold, the company has everything it needs to keep producing impressive gains for many years to come.3. BlockBlock (NYSE:SQ) is another high-growth stock that's been tumbling despite strong cash flows from operations. Shares of this money machine soared in 2020 and early 2021, but the party didn't last. The troubled fintech stock has lost more than 60% of its value since it peaked last summer, despite reporting $794 million in cash from operations over the past 12 months.Buying shares of Block is a great way for investors to keep a finger on the pulse of blockchain-based innovation without owning any specific currency directly. Block's payment processing business, Cash App, began allowing its users to trade Bitcoin in 2017. In order to facilitate transactions, the company's been amassing Bitcoin itself and finished September with a Bitcoin investment that had a carrying value of $149 million.Market prices pushed the fair value of Block's Bitcoins up to $352 million last September. While Bitcoin's previous gains have mostly been wiped out, Block's still in a position to complete heaps of blockchain-based transactions for everyday goods and services.At recent prices, you can buy Block shares for just 2.6 times forward sales expectations, which is awfully cheap for a company growing this fast. The company processed a whopping $45.4 billion worth of payments in the third quarter, which was 43% more than it processed a year earlier.","news_type":1,"symbols_score_info":{"COIN":1,"SQ":1,"SHOP":1}},"isVote":1,"tweetType":1,"viewCount":1581,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9004100355,"gmtCreate":1642518888018,"gmtModify":1676533718248,"author":{"id":"4090372448888540","authorId":"4090372448888540","name":"winfredcth","avatar":"https://static.tigerbbs.com/c465570918f25ab6c6a51f818aeceaf0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090372448888540","idStr":"4090372448888540"},"themes":[],"htmlText":"Yes","listText":"Yes","text":"Yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004100355","repostId":"1108209962","repostType":2,"repost":{"id":"1108209962","kind":"news","pubTimestamp":1641299915,"share":"https://ttm.financial/m/news/1108209962?lang=en_US&edition=fundamental","pubTime":"2022-01-04 20:38","market":"us","language":"en","title":"7 of the Best Energy Stocks for 2022 to Buy Now","url":"https://stock-news.laohu8.com/highlight/detail?id=1108209962","media":"InvestorPlace","summary":"Energy stocks have been easy to invest in for the last two years. At the onset of the pandemic in 20","content":"<div>\n<p>Energy stocks have been easy to invest in for the last two years. At the onset of the pandemic in 2020, energy stocks cratered because of a historic decline in demand. However, the U.S. economy began ...</p>\n\n<a href=\"https://investorplace.com/2022/01/7-best-energy-stocks-to-buy-for-2022/\">Source Link</a>\n\n</div>\n","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 of the Best Energy Stocks for 2022 to Buy Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 of the Best Energy Stocks for 2022 to Buy Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-04 20:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/01/7-best-energy-stocks-to-buy-for-2022/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Energy stocks have been easy to invest in for the last two years. At the onset of the pandemic in 2020, energy stocks cratered because of a historic decline in demand. However, the U.S. economy began ...</p>\n\n<a href=\"https://investorplace.com/2022/01/7-best-energy-stocks-to-buy-for-2022/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BEP":"Brookfield Renewable Partners LP","CVX":"雪佛龙","NEE":"新纪元能源","EPD":"Enterprise Products Partners L.P","ENPH":"Enphase Energy","MPC":"马拉松原油","CHPT":"ChargePoint Holdings Inc."},"source_url":"https://investorplace.com/2022/01/7-best-energy-stocks-to-buy-for-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108209962","content_text":"Energy stocks have been easy to invest in for the last two years. At the onset of the pandemic in 2020, energy stocks cratered because of a historic decline in demand. However, the U.S. economy began to open in early 2021 and demand increased.Just as that demand was increasing, the Biden administration took measures to slow down domestic supply. This created the perfect storm for traditional oil and gas stocks on one hand and renewable energy stocks on the other. The storm is likely to continue to blow through the market in 2022.Demand should remain high even with uncertainty about the virus. With inflation likely to remain high for the first half of the year, many investors will be looking to energy stocks for a reliable dividend.That doesn’t mean you can simply close your eyes and throw a dart at the energy sector, but it does mean that there’s an opportunity to buy some of the best-in-class stocks in both traditional and alternative energy companies.Here are seven energy stocks that can give your portfolio an all-of-the-above approach:Marathon Petroleum(NYSE:MPC)Chevron(NYSE:CVX)NextEra Energy(NYSE:NEE)Enterprise Product Partners(NYSE:EPD)Enphase(NASDAQ:ENPH)Brookfield Renewable Partners(NYSE:BEP)ChargePoint(NYSE:CHPT)Marathon Petroleum (MPC)As traditional oil and gas stocks go, you could do worse than investing in Marathon Petroleum.As 2021 kicked off, MPC stock was down nearly 30%. However, investors were already starting to see signs of a recovery. That’s because it was around that time that the first Covid-19 vaccines were being delivered.If you bought the stock at that time, you were rewarded with a gain of nearly 56%. Should investors expect that kind of return in 2022? That would seem unlikely. But oil prices are likely to remain high and analysts give the stock a gain of 13% in the next 12 months.Marathon pays a quarterly dividend that currently has a yield of 3.68% with a three-year average dividend growth of over 26%. The company has increased its dividend in each of the last nine years.Chevron (CVX)If you believe that a “both/and” approach will be required as a bridge to a cleaner energy future, then Chevron should definitely be in your consideration set.CVX stock is up 40% in the last 12 months, but that has analysts concerned that it may be near its peak. However, opportunistic investors may want to look at any dip as an opportunity to buy shares of this best-in-class oil and gas stock.Chevron CEO Mike Wirth gave an interview to Barron’s Streetwise this summer in which he predicted that oil and gas prices will remain high for the foreseeable future.Chevron is also making strategic investments in renewable energy, particularly renewable natural gas, renewable diesel and sustainable aviation fuel.Although the company has no plans to market wind or solar, it is investing in hydrogen and carbon capture as long-term opportunities.Chevron is a Dividend Aristocrat having increased its dividend in each of the last 34 years.NextEra Energy (NEE)There’s no reason to believe that clean energy is going to become less important. That alone is a reason to invest in NextEra Energy.However, when it comes to investing in energy stocks, location matters. That’s another good reason to buy NextEra Energy stock. The company is based in Florida and has over11 million residential customersthat help the company generate over $16 billion in annual revenue.With a stock that’s up nearly 25% in the last 12 months, it may be fair for investors to wonder if NextEra Energy is overvalued. One thing to consider is what analysts have to say and at this time, analysts still give NEE stock a buy rating.With NextEra Energy you also get one of the most reliable dividend stocks you can own. The company is a dividend aristocrat that has increased its dividend in each of the last 27 years. With three-year dividend growth of 38%, this is a strong performing dividend stock as well.Enterprise Product Partners (EPD)Dividend yield can be a misleading reason to buy a stock. But when you combine the possibility of a dividend yield of over 8% with a stock in a red-hot sector, you have a powerful combination.That’s what you get with Enterprise Product Partners.However, that’s not the only reason to buy EPD stock. The company boasts one of the largest scales and sizes in the industry. And this has resulted in the company having a steady and growing, distributable cash flow.This, in turn, fuels the dividend growth which the company has increased for the last 23 years. investors can still count on a little growth because of the company’s leadership in the sector.Analysts are giving a 12-month price target of $27.67, a nearly 26% upside from the stock’s price as 2022 kicks off.Enphase (ENPH)Enphase addresses a key limitation of solar power. Specifically, the company’s microinverter technology converts direct current power from solar panels to alternating current power.This allows efficient use of solar energy in the evening and on cloudy days. Another benefit of microinverter technology is that it reduces the possibility of a single point failure taking down an entire solar panel system.The company recently announced the launch of its IQ8 solar microinverters that makes them the first in the industry to provide a solution to power essential appliances during daytime solar panel outages even without a home battery.Furthermore, while Enphase generates over 80% of its revenue in the United States, it’s looking to expand internationally. One product, Ensemble-in-a-Box, is an infrastructure-light solution that is ideal for countries like India.As of this writing, ENPH stock is trading 54% its 52-week high. However, analysts give the stock a $244.78 price target that represents a34% upside from its current price.Brookfield Renewable Partners (BEP)For investors looking for a pure-play stock in renewable energy systems, Brookfield Renewable Partners is worthy of consideration.To begin with, Brookfield Renewable is one of the world’s largest publicly traded renewable power platforms.The company has a portfolio made up of nearly $58 billion assets under management in hydroelectric, wind, solar and storage projects spread over four continents.BEP stock is trading near its 52-week low which puts this dividend stock at an attractive price point for value-seeking investors.After cutting its dividend in 2020 in response to the pandemic, Brookfield increased its dividend in 2021. The dividend yield of 3.41% is slightly below the sector average, but it’s higher than the average of companies that trade on the New York Stock Exchange.BEP stock is a favorite of analysts who give it a consensus price target of $44.42 which would be 24% higher than the current stock price.ChargePoint (CHPT)ChargePoint has been a polarizing stock in 2021. In fact, down 51% for the year, CHPT stock could easily take the crown of one of 2021’s biggest losers.Some of this bearish sentiment has to do with the company being lumped in with the electric vehicle (EV) sector. Some of it has to do with the delay in the U.S. Congress passing the infrastructure bill that has money set aside for building out a charging station infrastructure.However, ChargePoint is an investment in “when” not “if.” If electric vehicles are going to become a mainstream alternative, a nationwide charging infrastructure will be a must.This is a crowded sector, but ChargePoint is among the leaders and is adapting its product line to provide solutions for battery packs that will allow consumers to charge wherever they are at (e.g. grocery store parking lots, entertainment venues, etc.).CHPT stock is trading near its 52-week low and analysts project a 64% upside for the stock.","news_type":1,"symbols_score_info":{"BEP":0.9,"CVX":0.9,"EPD":0.9,"ENPH":0.9,"NEE":0.9,"MPC":0.9,"CHPT":0.9}},"isVote":1,"tweetType":1,"viewCount":1456,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9005759882,"gmtCreate":1642422892053,"gmtModify":1676533709428,"author":{"id":"4090372448888540","authorId":"4090372448888540","name":"winfredcth","avatar":"https://static.tigerbbs.com/c465570918f25ab6c6a51f818aeceaf0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090372448888540","idStr":"4090372448888540"},"themes":[],"htmlText":"Gd","listText":"Gd","text":"Gd","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9005759882","repostId":"1142746712","repostType":4,"repost":{"id":"1142746712","kind":"news","pubTimestamp":1642421367,"share":"https://ttm.financial/m/news/1142746712?lang=en_US&edition=fundamental","pubTime":"2022-01-17 20:09","market":"us","language":"en","title":"With Growth Visibility, Palantir Deserves Its Premium Valuation","url":"https://stock-news.laohu8.com/highlight/detail?id=1142746712","media":"InvestorPlace","summary":"With top-line growth visibility and cash flow upside, the outlook is bullish for PLTR stock","content":"<div>\n<p>Palantir Technologies(NYSE:PLTR) stock surged to highs of $45 a year ago. The momentum failed to sustain and PLTR stock currently trades at $16.Even after the recent decline, the stock commands a ...</p>\n\n<a href=\"https://investorplace.com/2022/01/with-growth-visibility-pltr-stock-deserves-its-premium-valuation/\">Source Link</a>\n\n</div>\n","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>With Growth Visibility, Palantir Deserves Its Premium Valuation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWith Growth Visibility, Palantir Deserves Its Premium Valuation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-17 20:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/01/with-growth-visibility-pltr-stock-deserves-its-premium-valuation/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Palantir Technologies(NYSE:PLTR) stock surged to highs of $45 a year ago. The momentum failed to sustain and PLTR stock currently trades at $16.Even after the recent decline, the stock commands a ...</p>\n\n<a href=\"https://investorplace.com/2022/01/with-growth-visibility-pltr-stock-deserves-its-premium-valuation/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc."},"source_url":"https://investorplace.com/2022/01/with-growth-visibility-pltr-stock-deserves-its-premium-valuation/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1142746712","content_text":"Palantir Technologies(NYSE:PLTR) stock surged to highs of $45 a year ago. The momentum failed to sustain and PLTR stock currently trades at $16.Even after the recent decline, the stock commands a market capitalization of $32 billion. For the first nine months of 2021, Palantir Technologies reported revenue of $1.1 billion. This implies an annualized revenue potential of $1.5 billion.Given the current market capitalization, PLTR stock trades at 22x 2021 revenue. Therefore, in January 2021, the stock was trading at over 50x the revenue potential for 2021. The correction, therefore, didn’t come as a surprise.Is PLTR stock still overvalued?In my view, the stock still trades at a premium valuation. At the same time, I believe that Palantir deserves the valuation premium. In other words, current levels are attractive for accumulation and the best part of the correction might be over.My view is underscored by the point that eight analysts have a 12-month median price target of $24 for the stock. This implies an upside potential of 39%. The most bearish price target for the next 12 months is $15.Revenue Growth Likely to AcceleratePalantir has already been delivering robust growth. For the first nine months of 2021, the company reported revenue growth of 44% to $1.1 billion.Importantly, the company’s key margins have witnessed significant improvement. Palantir reported operating cash flow of $240 million in the first nine months of in 2021. For the prior year comparable period, cash burn was $278 million.Furthermore, Palantir guided for adjusted free cash flow of $400 million for 2021. Ultimately, valuations boil down to cash flows. I believe that cash flow will further accelerate.Let’s look at the key reasons.The order backlog for Palantir Technologies has witnessed acceleration. For Q3 2021, the company reported a backlog of $3.6 billion. On a year-over-year basis, the backlog swelled by 50%.Based on 2021 revenue guidance, the order backlog provides more than two years of revenue visibility. As the backlog continues to swell, valuations will adjust on the upside.The cryptocurrency world has been growing at a robust pace. Palantir Foundry is being touted as the “next generation software for next generation finance.” Palantir claims that the software has already helped financial organizations to lower their cost related to anti-money laundering by 90%. The software can be game-changing for the crypto space where billions have been lost due to hacks and scams.The Foundry for crypto also allows “Web3 startups to build complex workflows on top of dApp metadata.” It’s very likely that revenue contribution from the crypto space will increase meaningfully in the coming years.Palantir has guided for revenue growth in excess of 30% for the next four years. I would not be surprised if growth is well in excess of the lower end of the guidance.Concluding Views on PLTR StockPalantir has clients from industries that include defense, healthcare and automotive. Further, the company has critical solutions for the financial services industry. Sectors like defense and healthcare are likely to witness increased spending in the coming decade. Further, these sectors are insulated from economic shocks. This is likely to ensure that Palantir witnesses steady growth in its order backlog.From a financial perspective, Palantir reported cash and equivalents of $2.3 billion for Q3 2021. For the same quarter, the company reported an adjusted EBITDA margin of 30%. On a year-over-year basis, margin expanded by 400 basis points.With growth in order book and operating leverage, margin will expand. Free cash flows will also swell. The company therefore has ample financial flexibility to invest in innovation.Overall, PLTR stock looks attractive at current levels. After underperforming for most part of 2021, stock sentiment is likely to reverse in 2022.","news_type":1,"symbols_score_info":{"PLTR":0.9}},"isVote":1,"tweetType":1,"viewCount":1116,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006151177,"gmtCreate":1641655272140,"gmtModify":1676533637569,"author":{"id":"4090372448888540","authorId":"4090372448888540","name":"winfredcth","avatar":"https://static.tigerbbs.com/c465570918f25ab6c6a51f818aeceaf0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090372448888540","idStr":"4090372448888540"},"themes":[],"htmlText":"Yes","listText":"Yes","text":"Yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006151177","repostId":"1134509683","repostType":4,"repost":{"id":"1134509683","kind":"news","pubTimestamp":1641612579,"share":"https://ttm.financial/m/news/1134509683?lang=en_US&edition=fundamental","pubTime":"2022-01-08 11:29","market":"us","language":"en","title":"3 COVID Stocks That Will Make Billions in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=1134509683","media":"Motley Fool","summary":"These three COVID-19 stocks could rake in a tremendous amount of cash this year.","content":"<html><head></head><body><p>It&#39;s a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to make billions of dollars in 2022. Here are three stocks that should thrive.</p><p><b>Pfizer</b>(NYSE:PFE), the $310 billion mega cap, is expected to bring in not $1 billion or $10 billion but over $50 billion in sales for its COVID vaccine and antiviral pill. Scrappy <b>Novavax</b>(NASDAQ:NVAX)is finally introducing its COVID vaccine around the world. How many billions will it receive? And we have a dark horse candidate in <b>Vir Biotechnology</b>(NASDAQ:VIR). It has a drug that could easily be a $1 billion blockbuster for the tiny biotech.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/488a166201699c1f3d6536aa3e640ecf\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"/><span>IMAGE SOURCE: GETTY IMAGES.</span></p><p><b>A safe harbor in stormy weather</b></p><p><b>George Budwell(Pfizer):</b>Pfizer is the undisputed champion of COVID-19 pharmaceutical products. In 2022 alone, Wall Street expects the pharma giant to rake in $55 billion in sales between its novel coronavirus vaccine, Comirnaty, and its oral antiviral pill, Paxlovid.</p><p>What&#39;s more, analysts are starting to warm up to the idea that Paxlovid might be a sustainable revenue generator for the company over the course of the current decade. When the drug was first allowed on the market by the Food and Drug Administration under the Emergency Use Authorization pathway last month, Wall Street thought Paxlovid would likely peak from a commercial standpoint within a year or so, and then experience a dramatic drop in sales as the pandemic faded from view.</p><p>But less than three weeks out from the drug&#39;s initial approval, it is becoming painfully obvious that Paxlovid will probably be required as a fail-safe against the worst outcomes from COVID-19 for several more years. The highly infectious omicron variant, after all, will certainly not be the last major iteration of the virus.</p><p>What this all means is that Pfizer ought to be one of the few large-cap drugmakers with a sizable, long-term COVID-19 revenue source. Pfizer, in turn, should have ample free cash flows to feed its generous shareholder reward program, as well as its ambitious business development plans, for the foreseeable future.</p><p>So, if you&#39;re looking for a stock that can weather the dual headwinds of sky-high inflation and rising interest rates, Pfizer might be worth checking out.</p><p><b>Revenue forecasts for Novavax:  $2 billion to $8 billion</b></p><p><b>Taylor Carmichael(Novavax):</b>Novavax is on the verge of greatness this year. The company&#39;s stock price is down to $125 a share. That&#39;s where it started in 2021, so last year was pretty much a washout for the stock.</p><p>Back in February the share price zoomed over $300 when Novavax reported positive phase 3 data for its COVID vaccine. But then the small biotech ran into manufacturing issues. While its vaccine is said by many to be the best in class, scaling up the contract manufacturing for an estimated 2 billion doses of vaccine is easier said than done. And those realities have caused the stock to drop about 60% off its highs.</p><p>Nonetheless, Novavax has already hit the $1 billion revenue mark, so its vaccine was a blockbuster even before it was approved, because of all the preorders. Now that authorizations are pouring in from around the globe, it&#39;s highly likely that Novavax will ship a massive number of vaccine doses in 2022. The company&#39;s already achieved a manufacturing capacity of 100 million doses a month, or 1.2 billion doses in a year. On the third-quarter earnings call, management predicted it would reach a manufacturing capacity of 150 million doses every month (or 1.8 billion doses a year) by the end of the fourth quarter. And the company expects to continue to scale and forecasts that it will distribute 2 billion doses in 2022.</p><p>Two billion doses of vaccine, at a price point of $16 (Operation Warp Speed paid $1.6 billion to pre-order 100 million doses) gives us a back-of-the-envelope calculation of $32 billion in revenue. Of course, Novavax will be distributing a lot of vaccines to the developing world at a reduced rate. While the company has been quiet about its prices, Denmark said back in August that it paid almost $21 a dose under the European Union (EU) agreement. The EU has ordered 200 million doses, so that&#39;s over $4 billion in sales, just in Europe.</p><p>Analysts are being extremely conservative, with a forecast ranging from $2 billion to $8 billion for Novavax in 2022. (The company&#39;s market cap sits at $9 billion.) While there may be hiccups along the way, Novavax is sure to make billions of dollars off its COVID-19 vaccine in 2022. And there could be significant upside to the stock if the company does indeed deliver 2 billion doses as it says it will.</p><p><b>The antibody market all to itself</b></p><p><b>Patrick Bafuma(Vir Biotechnology):</b>The omicron variant is currently running rampant, and this time, we are short a few treatments. Previously favored monoclonal antibody treatments from <b>Eli Lilly</b> (bamlanivimab plus etesevimab) as well as the REGEN-COV cocktail from <b>Roche</b>and<b>Regeneron</b> are believed to have marked diminished activity against the current variant. This leaves a single infusiont hought to be active against omicron--<b>GlaxoSmithKline</b> and Vir Biotechnology&#39;s sotrovimab. This monoclonal antibody previously demonstrated a reduced risk of hospitalization and death by 79% in adults with mild to moderate COVID-19 and at high risk of progression to severe disease. And it&#39;s the only one left right now to fight the omicron variant.</p><p>Being the sole monoclonal antibody on the block will have its privileges. Through the first nine months of 2021, REGEN-COV brought in $3.5 billion in net product sales, while Eli Lilly&#39;s antibody combination brought in $1.17 billion. The U.S. government has already contracted for approximately $1 billion worth of sotrovimab. With hospitals overflowing with patients, anything that can help alleviate some of the stress on the system is likely going to be highly sought after.</p><p>And while Pfizer&#39;s Paxlovid will be hugely beneficial to ease the COVID-19 burden on the healthcare system, the oral medication has significant and complex drug-drug interaction potential. In fact, its interaction list reads like a who&#39;s who of commonly prescribed medications. This includes popular blood thinning agents such as Plavix and Xarelto, common analgesics like Tramadol and oxycodone, anxiolytics like Klonopin and Xanax, as well as cholesterol-fighting statins. With the National Institutes of Health issuing a statement voicing its concern over Paxlovid&#39;s possible drug interactions, this leaves plenty of room for sotrovimab to continue to be widely prescribed. With Vir getting 72.5% of sotrovimab sales per its agreement with GSK, the $4.4 billion biotech looks like a bargain right now.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 COVID Stocks That Will Make Billions in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 COVID Stocks That Will Make Billions in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-08 11:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It's a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞","VIR":"Vir Biotechnology, Inc."},"source_url":"https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134509683","content_text":"It's a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to make billions of dollars in 2022. Here are three stocks that should thrive.Pfizer(NYSE:PFE), the $310 billion mega cap, is expected to bring in not $1 billion or $10 billion but over $50 billion in sales for its COVID vaccine and antiviral pill. Scrappy Novavax(NASDAQ:NVAX)is finally introducing its COVID vaccine around the world. How many billions will it receive? And we have a dark horse candidate in Vir Biotechnology(NASDAQ:VIR). It has a drug that could easily be a $1 billion blockbuster for the tiny biotech.IMAGE SOURCE: GETTY IMAGES.A safe harbor in stormy weatherGeorge Budwell(Pfizer):Pfizer is the undisputed champion of COVID-19 pharmaceutical products. In 2022 alone, Wall Street expects the pharma giant to rake in $55 billion in sales between its novel coronavirus vaccine, Comirnaty, and its oral antiviral pill, Paxlovid.What's more, analysts are starting to warm up to the idea that Paxlovid might be a sustainable revenue generator for the company over the course of the current decade. When the drug was first allowed on the market by the Food and Drug Administration under the Emergency Use Authorization pathway last month, Wall Street thought Paxlovid would likely peak from a commercial standpoint within a year or so, and then experience a dramatic drop in sales as the pandemic faded from view.But less than three weeks out from the drug's initial approval, it is becoming painfully obvious that Paxlovid will probably be required as a fail-safe against the worst outcomes from COVID-19 for several more years. The highly infectious omicron variant, after all, will certainly not be the last major iteration of the virus.What this all means is that Pfizer ought to be one of the few large-cap drugmakers with a sizable, long-term COVID-19 revenue source. Pfizer, in turn, should have ample free cash flows to feed its generous shareholder reward program, as well as its ambitious business development plans, for the foreseeable future.So, if you're looking for a stock that can weather the dual headwinds of sky-high inflation and rising interest rates, Pfizer might be worth checking out.Revenue forecasts for Novavax:  $2 billion to $8 billionTaylor Carmichael(Novavax):Novavax is on the verge of greatness this year. The company's stock price is down to $125 a share. That's where it started in 2021, so last year was pretty much a washout for the stock.Back in February the share price zoomed over $300 when Novavax reported positive phase 3 data for its COVID vaccine. But then the small biotech ran into manufacturing issues. While its vaccine is said by many to be the best in class, scaling up the contract manufacturing for an estimated 2 billion doses of vaccine is easier said than done. And those realities have caused the stock to drop about 60% off its highs.Nonetheless, Novavax has already hit the $1 billion revenue mark, so its vaccine was a blockbuster even before it was approved, because of all the preorders. Now that authorizations are pouring in from around the globe, it's highly likely that Novavax will ship a massive number of vaccine doses in 2022. The company's already achieved a manufacturing capacity of 100 million doses a month, or 1.2 billion doses in a year. On the third-quarter earnings call, management predicted it would reach a manufacturing capacity of 150 million doses every month (or 1.8 billion doses a year) by the end of the fourth quarter. And the company expects to continue to scale and forecasts that it will distribute 2 billion doses in 2022.Two billion doses of vaccine, at a price point of $16 (Operation Warp Speed paid $1.6 billion to pre-order 100 million doses) gives us a back-of-the-envelope calculation of $32 billion in revenue. Of course, Novavax will be distributing a lot of vaccines to the developing world at a reduced rate. While the company has been quiet about its prices, Denmark said back in August that it paid almost $21 a dose under the European Union (EU) agreement. The EU has ordered 200 million doses, so that's over $4 billion in sales, just in Europe.Analysts are being extremely conservative, with a forecast ranging from $2 billion to $8 billion for Novavax in 2022. (The company's market cap sits at $9 billion.) While there may be hiccups along the way, Novavax is sure to make billions of dollars off its COVID-19 vaccine in 2022. And there could be significant upside to the stock if the company does indeed deliver 2 billion doses as it says it will.The antibody market all to itselfPatrick Bafuma(Vir Biotechnology):The omicron variant is currently running rampant, and this time, we are short a few treatments. Previously favored monoclonal antibody treatments from Eli Lilly (bamlanivimab plus etesevimab) as well as the REGEN-COV cocktail from RocheandRegeneron are believed to have marked diminished activity against the current variant. This leaves a single infusiont hought to be active against omicron--GlaxoSmithKline and Vir Biotechnology's sotrovimab. This monoclonal antibody previously demonstrated a reduced risk of hospitalization and death by 79% in adults with mild to moderate COVID-19 and at high risk of progression to severe disease. And it's the only one left right now to fight the omicron variant.Being the sole monoclonal antibody on the block will have its privileges. Through the first nine months of 2021, REGEN-COV brought in $3.5 billion in net product sales, while Eli Lilly's antibody combination brought in $1.17 billion. The U.S. government has already contracted for approximately $1 billion worth of sotrovimab. With hospitals overflowing with patients, anything that can help alleviate some of the stress on the system is likely going to be highly sought after.And while Pfizer's Paxlovid will be hugely beneficial to ease the COVID-19 burden on the healthcare system, the oral medication has significant and complex drug-drug interaction potential. In fact, its interaction list reads like a who's who of commonly prescribed medications. This includes popular blood thinning agents such as Plavix and Xarelto, common analgesics like Tramadol and oxycodone, anxiolytics like Klonopin and Xanax, as well as cholesterol-fighting statins. With the National Institutes of Health issuing a statement voicing its concern over Paxlovid's possible drug interactions, this leaves plenty of room for sotrovimab to continue to be widely prescribed. With Vir getting 72.5% of sotrovimab sales per its agreement with GSK, the $4.4 billion biotech looks like a bargain right now.","news_type":1,"symbols_score_info":{"NVAX":0.9,"VIR":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":1340,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006151992,"gmtCreate":1641655221631,"gmtModify":1676533637572,"author":{"id":"4090372448888540","authorId":"4090372448888540","name":"winfredcth","avatar":"https://static.tigerbbs.com/c465570918f25ab6c6a51f818aeceaf0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090372448888540","idStr":"4090372448888540"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006151992","repostId":"2201424321","repostType":4,"repost":{"id":"2201424321","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1641597180,"share":"https://ttm.financial/m/news/2201424321?lang=en_US&edition=fundamental","pubTime":"2022-01-08 07:13","market":"us","language":"en","title":"Wall St posts declines for first week of 2022; Nasdaq has worst week since Feb","url":"https://stock-news.laohu8.com/highlight/detail?id=2201424321","media":"Reuters","summary":"* U.S. nonfarm payrolls rise by 199,000 in December* GameStop jumps after report of foray into NFT, ","content":"<html><head></head><body><p>* U.S. nonfarm payrolls rise by 199,000 in December</p><p>* GameStop jumps after report of foray into NFT, crypto markets</p><p>* Indexes: Dow down 0.01%, S&amp;P 500 down 0.4%, Nasdaq down 1%</p><p>NEW YORK Jan 7 (Reuters) - Wall Street on Friday wrapped up the first week of the new year with daily and weekly losses as investors worried about looming U.S. interest-rate hikes and unfolding Omicron news.</p><p>The Nasdaq posted its biggest weekly percentage fall since February 2021 and led declines for the day in the major indexes. Stocks fell on Friday after the December U.S. jobs report missed expectations but was still seen as strong enough to keep the Federal Reserve&#39;s tightening path in place.</p><p>Friday&#39;s Labor Department data showed the U.S. jobs market was at or near maximum employment even though employment rose far less than expected in December, when there were worker shortages.</p><p>On Wednesday, minutes released of the Fed&#39;s Dec. 14-15 policy meeting showed officials at the U.S. central bank viewed the labor market as &#34;very tight,&#34; and signaled the Fed may have to raise rates sooner than expected.</p><p>&#34;The investor takeaway is that the labor market continues to be tight despite the headline miss,&#34; said Michael Arone, chief investment strategist at State Street Global Advisors in Boston.</p><p>&#34;Investors are concerned the Fed will be more aggressive than expected.&#34;</p><p>Consumer discretionary and and technology sectors led the way lower on the S&amp;P 500 on Friday. Big tech companies have benefited from low interest rates.</p><p>On the flip side, the S&amp;P 500 financials sector and banking index extended recent gains and reached record closing highs. The bank index rose 9.4% for the week, registering its biggest weekly percentage gain since November 2020.</p><p>The Dow Jones Industrial Average fell 4.81 points, or 0.01%, to 36,231.66, the S&amp;P 500 lost 19.02 points, or 0.41%, to 4,677.03 and the Nasdaq Composite dropped 144.96 points, or 0.96%, to 14,935.90.</p><p>For the week, the Dow fell 0.3%, the S&amp;P 500 declined 1.9% and the Nasdaq dropped 4.5%.</p><p>Banks have risen with U.S. Treasury yields, with the U.S. benchmark 10-year yield soaring to a two-year high on Friday on the outlook for Fed rate hikes.</p><p>&#34;The sentiment has turned negative,&#34; said Jack Dollarhide, chief executive officer of Longbow Asset Management in Tulsa, Oklahoma. &#34;Right now the market is nervous and in the mood to sell at the first hint of bad news.&#34;</p><p>Rising cases on the Omicron variant of the coronavirus also caused investor jitters this week.</p><p>Investors have been rotating out technology-heavy growth shares and into more value-oriented shares, which they think may do better in a high interest-rate environment.</p><p>The S&amp;P 500 value index added 1% this week, outperforming the S&amp;P 500 growth index which fell 4.5%, its biggest weekly percentage drop since October 2020.</p><p>The S&amp;P 500 energy sector gained sharply for the week, rising 10.6% in its best week since November 2020.</p><p>&#34;Meme stock&#34; GameStop Corp jumped 7.3% after the video game retailer said it is launching a division to develop a marketplace for nonfungible tokens and establish cryptocurrency partnerships.</p><p>Advancing issues outnumbered declining ones on the NYSE by a 1.01-to-1 ratio; on Nasdaq, a 1.38-to-1 ratio favored decliners.</p><p>The S&amp;P 500 posted 50 new 52-week highs and 1 new lows; the Nasdaq Composite recorded 83 new highs and 262 new lows.</p><p>Volume on U.S. exchanges was 10.21 billion shares, compared with the roughly 10.4 billion average for the full session over the last 20 trading days.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St posts declines for first week of 2022; Nasdaq has worst week since Feb</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St posts declines for first week of 2022; Nasdaq has worst week since Feb\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-01-08 07:13</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>* U.S. nonfarm payrolls rise by 199,000 in December</p><p>* GameStop jumps after report of foray into NFT, crypto markets</p><p>* Indexes: Dow down 0.01%, S&amp;P 500 down 0.4%, Nasdaq down 1%</p><p>NEW YORK Jan 7 (Reuters) - Wall Street on Friday wrapped up the first week of the new year with daily and weekly losses as investors worried about looming U.S. interest-rate hikes and unfolding Omicron news.</p><p>The Nasdaq posted its biggest weekly percentage fall since February 2021 and led declines for the day in the major indexes. Stocks fell on Friday after the December U.S. jobs report missed expectations but was still seen as strong enough to keep the Federal Reserve&#39;s tightening path in place.</p><p>Friday&#39;s Labor Department data showed the U.S. jobs market was at or near maximum employment even though employment rose far less than expected in December, when there were worker shortages.</p><p>On Wednesday, minutes released of the Fed&#39;s Dec. 14-15 policy meeting showed officials at the U.S. central bank viewed the labor market as &#34;very tight,&#34; and signaled the Fed may have to raise rates sooner than expected.</p><p>&#34;The investor takeaway is that the labor market continues to be tight despite the headline miss,&#34; said Michael Arone, chief investment strategist at State Street Global Advisors in Boston.</p><p>&#34;Investors are concerned the Fed will be more aggressive than expected.&#34;</p><p>Consumer discretionary and and technology sectors led the way lower on the S&amp;P 500 on Friday. Big tech companies have benefited from low interest rates.</p><p>On the flip side, the S&amp;P 500 financials sector and banking index extended recent gains and reached record closing highs. The bank index rose 9.4% for the week, registering its biggest weekly percentage gain since November 2020.</p><p>The Dow Jones Industrial Average fell 4.81 points, or 0.01%, to 36,231.66, the S&amp;P 500 lost 19.02 points, or 0.41%, to 4,677.03 and the Nasdaq Composite dropped 144.96 points, or 0.96%, to 14,935.90.</p><p>For the week, the Dow fell 0.3%, the S&amp;P 500 declined 1.9% and the Nasdaq dropped 4.5%.</p><p>Banks have risen with U.S. Treasury yields, with the U.S. benchmark 10-year yield soaring to a two-year high on Friday on the outlook for Fed rate hikes.</p><p>&#34;The sentiment has turned negative,&#34; said Jack Dollarhide, chief executive officer of Longbow Asset Management in Tulsa, Oklahoma. &#34;Right now the market is nervous and in the mood to sell at the first hint of bad news.&#34;</p><p>Rising cases on the Omicron variant of the coronavirus also caused investor jitters this week.</p><p>Investors have been rotating out technology-heavy growth shares and into more value-oriented shares, which they think may do better in a high interest-rate environment.</p><p>The S&amp;P 500 value index added 1% this week, outperforming the S&amp;P 500 growth index which fell 4.5%, its biggest weekly percentage drop since October 2020.</p><p>The S&amp;P 500 energy sector gained sharply for the week, rising 10.6% in its best week since November 2020.</p><p>&#34;Meme stock&#34; GameStop Corp jumped 7.3% after the video game retailer said it is launching a division to develop a marketplace for nonfungible tokens and establish cryptocurrency partnerships.</p><p>Advancing issues outnumbered declining ones on the NYSE by a 1.01-to-1 ratio; on Nasdaq, a 1.38-to-1 ratio favored decliners.</p><p>The S&amp;P 500 posted 50 new 52-week highs and 1 new lows; the Nasdaq Composite recorded 83 new highs and 262 new lows.</p><p>Volume on U.S. exchanges was 10.21 billion shares, compared with the roughly 10.4 billion average for the full session over the last 20 trading days.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GME":"游戏驿站",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2201424321","content_text":"* U.S. nonfarm payrolls rise by 199,000 in December* GameStop jumps after report of foray into NFT, crypto markets* Indexes: Dow down 0.01%, S&P 500 down 0.4%, Nasdaq down 1%NEW YORK Jan 7 (Reuters) - Wall Street on Friday wrapped up the first week of the new year with daily and weekly losses as investors worried about looming U.S. interest-rate hikes and unfolding Omicron news.The Nasdaq posted its biggest weekly percentage fall since February 2021 and led declines for the day in the major indexes. Stocks fell on Friday after the December U.S. jobs report missed expectations but was still seen as strong enough to keep the Federal Reserve's tightening path in place.Friday's Labor Department data showed the U.S. jobs market was at or near maximum employment even though employment rose far less than expected in December, when there were worker shortages.On Wednesday, minutes released of the Fed's Dec. 14-15 policy meeting showed officials at the U.S. central bank viewed the labor market as \"very tight,\" and signaled the Fed may have to raise rates sooner than expected.\"The investor takeaway is that the labor market continues to be tight despite the headline miss,\" said Michael Arone, chief investment strategist at State Street Global Advisors in Boston.\"Investors are concerned the Fed will be more aggressive than expected.\"Consumer discretionary and and technology sectors led the way lower on the S&P 500 on Friday. Big tech companies have benefited from low interest rates.On the flip side, the S&P 500 financials sector and banking index extended recent gains and reached record closing highs. The bank index rose 9.4% for the week, registering its biggest weekly percentage gain since November 2020.The Dow Jones Industrial Average fell 4.81 points, or 0.01%, to 36,231.66, the S&P 500 lost 19.02 points, or 0.41%, to 4,677.03 and the Nasdaq Composite dropped 144.96 points, or 0.96%, to 14,935.90.For the week, the Dow fell 0.3%, the S&P 500 declined 1.9% and the Nasdaq dropped 4.5%.Banks have risen with U.S. Treasury yields, with the U.S. benchmark 10-year yield soaring to a two-year high on Friday on the outlook for Fed rate hikes.\"The sentiment has turned negative,\" said Jack Dollarhide, chief executive officer of Longbow Asset Management in Tulsa, Oklahoma. \"Right now the market is nervous and in the mood to sell at the first hint of bad news.\"Rising cases on the Omicron variant of the coronavirus also caused investor jitters this week.Investors have been rotating out technology-heavy growth shares and into more value-oriented shares, which they think may do better in a high interest-rate environment.The S&P 500 value index added 1% this week, outperforming the S&P 500 growth index which fell 4.5%, its biggest weekly percentage drop since October 2020.The S&P 500 energy sector gained sharply for the week, rising 10.6% in its best week since November 2020.\"Meme stock\" GameStop Corp jumped 7.3% after the video game retailer said it is launching a division to develop a marketplace for nonfungible tokens and establish cryptocurrency partnerships.Advancing issues outnumbered declining ones on the NYSE by a 1.01-to-1 ratio; on Nasdaq, a 1.38-to-1 ratio favored decliners.The S&P 500 posted 50 new 52-week highs and 1 new lows; the Nasdaq Composite recorded 83 new highs and 262 new lows.Volume on U.S. exchanges was 10.21 billion shares, compared with the roughly 10.4 billion average for the full session over the last 20 trading days.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,"NQmain":1,"GME":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":1185,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001703121,"gmtCreate":1641310460267,"gmtModify":1676533596438,"author":{"id":"4090372448888540","authorId":"4090372448888540","name":"winfredcth","avatar":"https://static.tigerbbs.com/c465570918f25ab6c6a51f818aeceaf0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090372448888540","idStr":"4090372448888540"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001703121","repostId":"2200406435","repostType":4,"repost":{"id":"2200406435","kind":"highlight","pubTimestamp":1641310325,"share":"https://ttm.financial/m/news/2200406435?lang=en_US&edition=fundamental","pubTime":"2022-01-04 23:32","market":"us","language":"en","title":"3 Wildly Undervalued Stocks to Buy and Hold for the Next Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2200406435","media":"Motley Fool","summary":"Strong free cash flow and high growth rates are a winning combo.","content":"<div>\n<p>One of the hardest lessons for me as a new investor was to stop filtering out great, high-quality stocks that looked expensive by most traditional valuation metrics. Instead, I sought standard \"value\"...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/04/3-wildly-undervalued-stocks-to-buy-and-hold-for-th/\">Source Link</a>\n\n</div>\n","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Wildly Undervalued Stocks to Buy and Hold for the Next Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Wildly Undervalued Stocks to Buy and Hold for the Next Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-04 23:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/04/3-wildly-undervalued-stocks-to-buy-and-hold-for-th/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>One of the hardest lessons for me as a new investor was to stop filtering out great, high-quality stocks that looked expensive by most traditional valuation metrics. Instead, I sought standard \"value\"...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/04/3-wildly-undervalued-stocks-to-buy-and-hold-for-th/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FCF":"第一联邦金融","BK4077":"互动媒体与服务","BK4551":"寇图资本持仓","BK4525":"远程办公概念","BK4211":"区域性银行","BK4554":"元宇宙及AR概念","BK4528":"SaaS概念","BK4023":"应用软件","BK4534":"瑞士信贷持仓","BK4548":"巴美列捷福持仓","BK4505":"高瓴资本持仓","DOCU":"Docusign","BK4535":"淡马锡持仓","BK4508":"社交媒体","PINS":"Pinterest, Inc.","BK4532":"文艺复兴科技持仓","ZM":"Zoom"},"source_url":"https://www.fool.com/investing/2022/01/04/3-wildly-undervalued-stocks-to-buy-and-hold-for-th/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2200406435","content_text":"One of the hardest lessons for me as a new investor was to stop filtering out great, high-quality stocks that looked expensive by most traditional valuation metrics. Instead, I sought standard \"value\" and found companies that were incredibly cheap, but often seriously broken, that unfortunately deserved their discounted valuations.By simply accepting that most premium stocks trade at expensive-looking valuations, I entered the land of long-term investing and ultimately multibagger potential.Today we will study Zoom Video Communications (NASDAQ:ZM), Pinterest (NYSE:PINS), and DocuSign (NASDAQ:DOCU), three stocks that fit this expensive-looking mold, yet could be wildly undervalued when looking out over the next decade, thanks to their high revenue growth and strong free cash flow (FCF) generation.High growth at intriguing valuationsMarket CapLevered FCFP/FCF RatioRevenue Growth YOYZoom Video$55 billion$1.51 billion36100%Pinterest$24 billion$470 million5176%DocuSign$29 billion$753 million3951%Data source: Yahoo! Finance and CMLViz statistics. Note that Levered FCF and Revenue Growth are using trailing 12-month figures. YOY = year over year. FCF = free cash flow. P/FCF = price-to-FCF.While highly unscientific, one of my favorite ways to measure a stock's growth potential versus its current price is to compare year-over-year revenue growth with its price-to-FCF ratio. As shown in the table above, Zoom, Pinterest, and DocuSign all have a growth rate higher than their FCF multiples.Whenever a stock's growth rate is higher than its FCF multiple, it catches my attention, highlighting the beautiful combination of solid sales growth with reasonably priced cash generation. With that in mind, let's look at my three recommendations.1. Zoom Video CommunicationsFirst up today is the fastest growing and cheapest valuation of the trio, Zoom Video Communications. Because its share price has dropped nearly 50% over the last six months amid decelerating sales growth, Zoom looks attractively valued compared to the $1.5 billion in free cash flow it created over the previous 12 months.While its 100% revenue growth over the last 12 months will probably not repeat in 2022, its third-quarter growth of 35% year over year is more than enough to make its freshly discounted valuation appealing. Furthermore, with 14 consecutive quarters with a dollar-based net expansion (DBNE) rate above 130%, Zoom has demonstrated that its land-and-expand business model is firing on all cylinders.DBNE is a great way to measure increased product use by existing customers, despite not accounting for customer churn. For Zoom, this 130% rate is highly promising as it shows that it is getting its foot in the door with its famous Meetings product and upselling customers on newer products, such as Zoom Rooms and Zoom Phone. Should the company's DBNE continue at these levels, it will signal that its business model is still succeeding.Furthermore, with international sales only accounting for 33% of Zoom's total revenue, its global ambitions are still in their infancy. This international growth runway, paired with the company's strong FCF and recently discounted share price, makes Zoom a great core holding for the next decade.2. PinterestNext up, we have Pinterest with its inspiration-creating platform and newly developed FCF generation. Unfortunately, despite the promise of these positive cash flows, Pinterest's stock has dropped over 50% in the last six months, due to a rumored abandoned acquisition by PayPal and a decline in monthly active users (MAUs).But two key things are happening behind the scenes for Pinterest, making today's valuation very tempting.First, the company's fledgling shopping features are starting to take off, with product searches up over 100% for the third quarter, year over year. Better yet, members of the all-important Generation Z demographic (ages 9 to 24) increased their product searches on the shop tab by over 200% for the third quarter.Second, despite having four times the number of international MAUs than in the U.S., the international segment only accounts for 21% of Pinterest's overall revenue. This is due to the massive gap in average revenue per user (ARPU) between U.S. and international users, which is $5.55 and $0.38, respectively.This gap is essential for investors to watch as Pinterest launched its shopping features in seven key international markets during the third quarter: Italy, Spain, the Netherlands, Austria, Switzerland, Brazil, and Mexico. As these markets mature, along with Pinterest's shopping features in general, investors should see this ARPU gap between the U.S. and international narrow, bringing strong monetization to the company's global footprint.3. DocuSignFamous for its e-signature product, DocuSign is on a mission to prove that it is more than just a one-trick pony. Moving beyond its e-signature dominance, the company has its eyes set on a broader target market that it hopes to serve through its Agreement Cloud, which consists of four segments: prepare, sign, act, and manage.With its Agreement Cloud, DocuSign intends to parlay its leadership in e-signatures into becoming the leader in automated end-to-end agreement processes. While the company does not break out numbers for each segment of the Agreement Cloud, we can get a good idea of its ongoing success through DocuSign's 121% dollar-based net retention (DBNR) rate.DBNR shows the rate at which existing customers are expanding their use of the company's products. Since DBNR includes customer churn, a figure above 120% is exceptional. So DocuSign's track record of being above this mark for six consecutive quarters is very impressive. It highlights the potential that might be building within the company's broader Agreement Cloud ambitions. And that makes DocuSign's 30% share-price drop in the last month an appealing entry point for new investors.DocuSign already has a 17% FCF margin, which makes it look like another discounted, but strong, cash-generating stock to buy and hold for the next decade.","news_type":1,"symbols_score_info":{"FCF":1,"DOCU":1,"PINS":1,"ZM":1}},"isVote":1,"tweetType":1,"viewCount":1235,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9003731635,"gmtCreate":1641084184127,"gmtModify":1676533569799,"author":{"id":"4090372448888540","authorId":"4090372448888540","name":"winfredcth","avatar":"https://static.tigerbbs.com/c465570918f25ab6c6a51f818aeceaf0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090372448888540","idStr":"4090372448888540"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9003731635","repostId":"693818240","repostType":1,"repost":{"id":693818240,"gmtCreate":1639999281878,"gmtModify":1676532386196,"author":{"id":"3574309605005459","authorId":"3574309605005459","name":"Palantard SG","avatar":"https://static.itradeup.com/news/337dc13df0a91652d56aab40db13a130","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3574309605005459","idStr":"3574309605005459"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>When people are not successful in their lives, they automatically assume you can’t be successful and if you are, you’re leveraging on ur father’s money. Funny thing is, I lost my dad when I was 3.&nbsp;Salary is coming in. 20,800 shares isn’t enough. Goal is to hit 25k shares if possible. Off to work!&nbsp;","listText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>When people are not successful in their lives, they automatically assume you can’t be successful and if you are, you’re leveraging on ur father’s money. Funny thing is, I lost my dad when I was 3.&nbsp;Salary is coming in. 20,800 shares isn’t enough. Goal is to hit 25k shares if possible. Off to work!&nbsp;","text":"$Palantir Technologies Inc.(PLTR)$When people are not successful in their lives, they automatically assume you can’t be successful and if you are, you’re leveraging on ur father’s money. Funny thing is, I lost my dad when I was 3. Salary is coming in. 20,800 shares isn’t enough. Goal is to hit 25k shares if possible. Off to work!","images":[{"img":"https://static.tigerbbs.com/fd65dcb1bdb88a22843c4079d0c7ba21","width":"1170","height":"2532"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/693818240","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1146,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":889223846,"gmtCreate":1631152281785,"gmtModify":1676530481215,"author":{"id":"4090372448888540","authorId":"4090372448888540","name":"winfredcth","avatar":"https://static.tigerbbs.com/c465570918f25ab6c6a51f818aeceaf0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090372448888540","idStr":"4090372448888540"},"themes":[],"htmlText":"Wow..gd to know&nbsp;","listText":"Wow..gd to know&nbsp;","text":"Wow..gd to know","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/889223846","repostId":"1140686239","repostType":2,"isVote":1,"tweetType":1,"viewCount":644,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":815395285,"gmtCreate":1630641475747,"gmtModify":1676530364316,"author":{"id":"4090372448888540","authorId":"4090372448888540","name":"winfredcth","avatar":"https://static.tigerbbs.com/c465570918f25ab6c6a51f818aeceaf0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090372448888540","idStr":"4090372448888540"},"themes":[],"htmlText":"Gd to invest now","listText":"Gd to invest now","text":"Gd to invest now","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/815395285","repostId":"1129167710","repostType":4,"isVote":1,"tweetType":1,"viewCount":1028,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":815392237,"gmtCreate":1630641349329,"gmtModify":1676530364292,"author":{"id":"4090372448888540","authorId":"4090372448888540","name":"winfredcth","avatar":"https://static.tigerbbs.com/c465570918f25ab6c6a51f818aeceaf0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090372448888540","idStr":"4090372448888540"},"themes":[],"htmlText":"Gd to know","listText":"Gd to know","text":"Gd to know","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/815392237","repostId":"2164829818","repostType":4,"isVote":1,"tweetType":1,"viewCount":1183,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":815395285,"gmtCreate":1630641475747,"gmtModify":1676530364316,"author":{"id":"4090372448888540","authorId":"4090372448888540","name":"winfredcth","avatar":"https://static.tigerbbs.com/c465570918f25ab6c6a51f818aeceaf0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090372448888540","authorIdStr":"4090372448888540"},"themes":[],"htmlText":"Gd to invest now","listText":"Gd to invest now","text":"Gd to invest now","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/815395285","repostId":"1129167710","repostType":4,"isVote":1,"tweetType":1,"viewCount":1028,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9092845465,"gmtCreate":1644593132918,"gmtModify":1676533944667,"author":{"id":"4090372448888540","authorId":"4090372448888540","name":"winfredcth","avatar":"https://static.tigerbbs.com/c465570918f25ab6c6a51f818aeceaf0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090372448888540","authorIdStr":"4090372448888540"},"themes":[],"htmlText":"Gd","listText":"Gd","text":"Gd","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9092845465","repostId":"1191871987","repostType":4,"repost":{"id":"1191871987","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1644590744,"share":"https://ttm.financial/m/news/1191871987?lang=en_US&edition=fundamental","pubTime":"2022-02-11 22:45","market":"us","language":"en","title":"Block Stock Jumped 6% in Morning Trading after BofA and Citi Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1191871987","media":"Tiger Newspress","summary":"Block stock jumped 6% in morning trading after BofA and Citi Buy ratingBofA analyst Jason Kupferberg","content":"<html><head></head><body><p>Block stock jumped 6% in morning trading after BofA and Citi Buy rating<img src=\"https://static.tigerbbs.com/cbb193c0641f24519c680ade98388335\" tg-width=\"1116\" tg-height=\"764\" referrerpolicy=\"no-referrer\"/>BofA analyst Jason Kupferberg upgraded to Buy from Neutral with a price target of $185.00 per share, down from $221.00. The analyst sees a discount in shares as the market is undervaluing the Cash App value.</p><p>“Following big underperformance in shares of SQ, we conducted a sum-of-the-parts (SOTP) analysis, which suggests the market is currently ascribing only ~$6.5B of value to Cash App, or ~$93 per annual active user vs. PYPL at $326 and AFRM at $1,472. Shares have lagged due to a combination of the general growth sell-off and continued limited visibility on the near-term and medium-term trajectory of Cash App gross profit (GP) growth, where concerns became further heightened following PYPL’s commentary on 2/1/22 regarding weakness in post-stimulus spending among lower-income cohorts. Headlines regarding Apple’s introduction of iPhone-based card acceptance have also weighed on SQ,” Kupferberg said in a client note.</p><p>Citi analyst Peter Christiansen resumed research coverage on Block with a Buy, $220.00 price target.</p><p>“We see the SQ+APT value creation opportunity to be more than just (i) ecosystem integration or (ii) a globalization accelerant – two very powerful rationales nonetheless. For us, we see the combination expanding both the new product development canvas (TAM vectors), as well as Block’s product development capabilities (asset extensions, time-to-market, differentiation),” Christiansen wrote in the report.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Block Stock Jumped 6% in Morning Trading after BofA and Citi Buy Rating</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBlock Stock Jumped 6% in Morning Trading after BofA and Citi Buy Rating\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-02-11 22:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Block stock jumped 6% in morning trading after BofA and Citi Buy rating<img src=\"https://static.tigerbbs.com/cbb193c0641f24519c680ade98388335\" tg-width=\"1116\" tg-height=\"764\" referrerpolicy=\"no-referrer\"/>BofA analyst Jason Kupferberg upgraded to Buy from Neutral with a price target of $185.00 per share, down from $221.00. The analyst sees a discount in shares as the market is undervaluing the Cash App value.</p><p>“Following big underperformance in shares of SQ, we conducted a sum-of-the-parts (SOTP) analysis, which suggests the market is currently ascribing only ~$6.5B of value to Cash App, or ~$93 per annual active user vs. PYPL at $326 and AFRM at $1,472. Shares have lagged due to a combination of the general growth sell-off and continued limited visibility on the near-term and medium-term trajectory of Cash App gross profit (GP) growth, where concerns became further heightened following PYPL’s commentary on 2/1/22 regarding weakness in post-stimulus spending among lower-income cohorts. Headlines regarding Apple’s introduction of iPhone-based card acceptance have also weighed on SQ,” Kupferberg said in a client note.</p><p>Citi analyst Peter Christiansen resumed research coverage on Block with a Buy, $220.00 price target.</p><p>“We see the SQ+APT value creation opportunity to be more than just (i) ecosystem integration or (ii) a globalization accelerant – two very powerful rationales nonetheless. For us, we see the combination expanding both the new product development canvas (TAM vectors), as well as Block’s product development capabilities (asset extensions, time-to-market, differentiation),” Christiansen wrote in the report.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191871987","content_text":"Block stock jumped 6% in morning trading after BofA and Citi Buy ratingBofA analyst Jason Kupferberg upgraded to Buy from Neutral with a price target of $185.00 per share, down from $221.00. The analyst sees a discount in shares as the market is undervaluing the Cash App value.“Following big underperformance in shares of SQ, we conducted a sum-of-the-parts (SOTP) analysis, which suggests the market is currently ascribing only ~$6.5B of value to Cash App, or ~$93 per annual active user vs. PYPL at $326 and AFRM at $1,472. Shares have lagged due to a combination of the general growth sell-off and continued limited visibility on the near-term and medium-term trajectory of Cash App gross profit (GP) growth, where concerns became further heightened following PYPL’s commentary on 2/1/22 regarding weakness in post-stimulus spending among lower-income cohorts. Headlines regarding Apple’s introduction of iPhone-based card acceptance have also weighed on SQ,” Kupferberg said in a client note.Citi analyst Peter Christiansen resumed research coverage on Block with a Buy, $220.00 price target.“We see the SQ+APT value creation opportunity to be more than just (i) ecosystem integration or (ii) a globalization accelerant – two very powerful rationales nonetheless. For us, we see the combination expanding both the new product development canvas (TAM vectors), as well as Block’s product development capabilities (asset extensions, time-to-market, differentiation),” Christiansen wrote in the report.","news_type":1,"symbols_score_info":{"SQ":0.9}},"isVote":1,"tweetType":1,"viewCount":3927,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9910820316,"gmtCreate":1663597535236,"gmtModify":1676537298543,"author":{"id":"4090372448888540","authorId":"4090372448888540","name":"winfredcth","avatar":"https://static.tigerbbs.com/c465570918f25ab6c6a51f818aeceaf0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090372448888540","authorIdStr":"4090372448888540"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/9910820316","repostId":"1158905038","repostType":4,"isVote":1,"tweetType":1,"viewCount":4011,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":815392237,"gmtCreate":1630641349329,"gmtModify":1676530364292,"author":{"id":"4090372448888540","authorId":"4090372448888540","name":"winfredcth","avatar":"https://static.tigerbbs.com/c465570918f25ab6c6a51f818aeceaf0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090372448888540","authorIdStr":"4090372448888540"},"themes":[],"htmlText":"Gd to know","listText":"Gd to know","text":"Gd to know","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/815392237","repostId":"2164829818","repostType":4,"isVote":1,"tweetType":1,"viewCount":1183,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":813239561,"gmtCreate":1630203668753,"gmtModify":1676530242325,"author":{"id":"4090372448888540","authorId":"4090372448888540","name":"winfredcth","avatar":"https://static.tigerbbs.com/c465570918f25ab6c6a51f818aeceaf0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090372448888540","authorIdStr":"4090372448888540"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>#freeappleshare","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>#freeappleshare","text":"$Apple(AAPL)$#freeappleshare","images":[{"img":"https://static.tigerbbs.com/045b8a1076702c528bbb124e36f0a7b1","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/813239561","isVote":1,"tweetType":1,"viewCount":657,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":889223846,"gmtCreate":1631152281785,"gmtModify":1676530481215,"author":{"id":"4090372448888540","authorId":"4090372448888540","name":"winfredcth","avatar":"https://static.tigerbbs.com/c465570918f25ab6c6a51f818aeceaf0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090372448888540","authorIdStr":"4090372448888540"},"themes":[],"htmlText":"Wow..gd to know&nbsp;","listText":"Wow..gd to know&nbsp;","text":"Wow..gd to know","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/889223846","repostId":"1140686239","repostType":2,"isVote":1,"tweetType":1,"viewCount":644,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001703121,"gmtCreate":1641310460267,"gmtModify":1676533596438,"author":{"id":"4090372448888540","authorId":"4090372448888540","name":"winfredcth","avatar":"https://static.tigerbbs.com/c465570918f25ab6c6a51f818aeceaf0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090372448888540","authorIdStr":"4090372448888540"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001703121","repostId":"2200406435","repostType":4,"repost":{"id":"2200406435","kind":"highlight","pubTimestamp":1641310325,"share":"https://ttm.financial/m/news/2200406435?lang=en_US&edition=fundamental","pubTime":"2022-01-04 23:32","market":"us","language":"en","title":"3 Wildly Undervalued Stocks to Buy and Hold for the Next Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2200406435","media":"Motley Fool","summary":"Strong free cash flow and high growth rates are a winning combo.","content":"<div>\n<p>One of the hardest lessons for me as a new investor was to stop filtering out great, high-quality stocks that looked expensive by most traditional valuation metrics. Instead, I sought standard \"value\"...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/04/3-wildly-undervalued-stocks-to-buy-and-hold-for-th/\">Source Link</a>\n\n</div>\n","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Wildly Undervalued Stocks to Buy and Hold for the Next Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Wildly Undervalued Stocks to Buy and Hold for the Next Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-04 23:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/04/3-wildly-undervalued-stocks-to-buy-and-hold-for-th/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>One of the hardest lessons for me as a new investor was to stop filtering out great, high-quality stocks that looked expensive by most traditional valuation metrics. Instead, I sought standard \"value\"...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/04/3-wildly-undervalued-stocks-to-buy-and-hold-for-th/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FCF":"第一联邦金融","BK4077":"互动媒体与服务","BK4551":"寇图资本持仓","BK4525":"远程办公概念","BK4211":"区域性银行","BK4554":"元宇宙及AR概念","BK4528":"SaaS概念","BK4023":"应用软件","BK4534":"瑞士信贷持仓","BK4548":"巴美列捷福持仓","BK4505":"高瓴资本持仓","DOCU":"Docusign","BK4535":"淡马锡持仓","BK4508":"社交媒体","PINS":"Pinterest, Inc.","BK4532":"文艺复兴科技持仓","ZM":"Zoom"},"source_url":"https://www.fool.com/investing/2022/01/04/3-wildly-undervalued-stocks-to-buy-and-hold-for-th/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2200406435","content_text":"One of the hardest lessons for me as a new investor was to stop filtering out great, high-quality stocks that looked expensive by most traditional valuation metrics. Instead, I sought standard \"value\" and found companies that were incredibly cheap, but often seriously broken, that unfortunately deserved their discounted valuations.By simply accepting that most premium stocks trade at expensive-looking valuations, I entered the land of long-term investing and ultimately multibagger potential.Today we will study Zoom Video Communications (NASDAQ:ZM), Pinterest (NYSE:PINS), and DocuSign (NASDAQ:DOCU), three stocks that fit this expensive-looking mold, yet could be wildly undervalued when looking out over the next decade, thanks to their high revenue growth and strong free cash flow (FCF) generation.High growth at intriguing valuationsMarket CapLevered FCFP/FCF RatioRevenue Growth YOYZoom Video$55 billion$1.51 billion36100%Pinterest$24 billion$470 million5176%DocuSign$29 billion$753 million3951%Data source: Yahoo! Finance and CMLViz statistics. Note that Levered FCF and Revenue Growth are using trailing 12-month figures. YOY = year over year. FCF = free cash flow. P/FCF = price-to-FCF.While highly unscientific, one of my favorite ways to measure a stock's growth potential versus its current price is to compare year-over-year revenue growth with its price-to-FCF ratio. As shown in the table above, Zoom, Pinterest, and DocuSign all have a growth rate higher than their FCF multiples.Whenever a stock's growth rate is higher than its FCF multiple, it catches my attention, highlighting the beautiful combination of solid sales growth with reasonably priced cash generation. With that in mind, let's look at my three recommendations.1. Zoom Video CommunicationsFirst up today is the fastest growing and cheapest valuation of the trio, Zoom Video Communications. Because its share price has dropped nearly 50% over the last six months amid decelerating sales growth, Zoom looks attractively valued compared to the $1.5 billion in free cash flow it created over the previous 12 months.While its 100% revenue growth over the last 12 months will probably not repeat in 2022, its third-quarter growth of 35% year over year is more than enough to make its freshly discounted valuation appealing. Furthermore, with 14 consecutive quarters with a dollar-based net expansion (DBNE) rate above 130%, Zoom has demonstrated that its land-and-expand business model is firing on all cylinders.DBNE is a great way to measure increased product use by existing customers, despite not accounting for customer churn. For Zoom, this 130% rate is highly promising as it shows that it is getting its foot in the door with its famous Meetings product and upselling customers on newer products, such as Zoom Rooms and Zoom Phone. Should the company's DBNE continue at these levels, it will signal that its business model is still succeeding.Furthermore, with international sales only accounting for 33% of Zoom's total revenue, its global ambitions are still in their infancy. This international growth runway, paired with the company's strong FCF and recently discounted share price, makes Zoom a great core holding for the next decade.2. PinterestNext up, we have Pinterest with its inspiration-creating platform and newly developed FCF generation. Unfortunately, despite the promise of these positive cash flows, Pinterest's stock has dropped over 50% in the last six months, due to a rumored abandoned acquisition by PayPal and a decline in monthly active users (MAUs).But two key things are happening behind the scenes for Pinterest, making today's valuation very tempting.First, the company's fledgling shopping features are starting to take off, with product searches up over 100% for the third quarter, year over year. Better yet, members of the all-important Generation Z demographic (ages 9 to 24) increased their product searches on the shop tab by over 200% for the third quarter.Second, despite having four times the number of international MAUs than in the U.S., the international segment only accounts for 21% of Pinterest's overall revenue. This is due to the massive gap in average revenue per user (ARPU) between U.S. and international users, which is $5.55 and $0.38, respectively.This gap is essential for investors to watch as Pinterest launched its shopping features in seven key international markets during the third quarter: Italy, Spain, the Netherlands, Austria, Switzerland, Brazil, and Mexico. As these markets mature, along with Pinterest's shopping features in general, investors should see this ARPU gap between the U.S. and international narrow, bringing strong monetization to the company's global footprint.3. DocuSignFamous for its e-signature product, DocuSign is on a mission to prove that it is more than just a one-trick pony. Moving beyond its e-signature dominance, the company has its eyes set on a broader target market that it hopes to serve through its Agreement Cloud, which consists of four segments: prepare, sign, act, and manage.With its Agreement Cloud, DocuSign intends to parlay its leadership in e-signatures into becoming the leader in automated end-to-end agreement processes. While the company does not break out numbers for each segment of the Agreement Cloud, we can get a good idea of its ongoing success through DocuSign's 121% dollar-based net retention (DBNR) rate.DBNR shows the rate at which existing customers are expanding their use of the company's products. Since DBNR includes customer churn, a figure above 120% is exceptional. So DocuSign's track record of being above this mark for six consecutive quarters is very impressive. It highlights the potential that might be building within the company's broader Agreement Cloud ambitions. And that makes DocuSign's 30% share-price drop in the last month an appealing entry point for new investors.DocuSign already has a 17% FCF margin, which makes it look like another discounted, but strong, cash-generating stock to buy and hold for the next decade.","news_type":1,"symbols_score_info":{"FCF":1,"DOCU":1,"PINS":1,"ZM":1}},"isVote":1,"tweetType":1,"viewCount":1235,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9090140518,"gmtCreate":1643125166942,"gmtModify":1676533776521,"author":{"id":"4090372448888540","authorId":"4090372448888540","name":"winfredcth","avatar":"https://static.tigerbbs.com/c465570918f25ab6c6a51f818aeceaf0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090372448888540","authorIdStr":"4090372448888540"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9090140518","repostId":"2206351468","repostType":4,"repost":{"id":"2206351468","kind":"highlight","pubTimestamp":1643123844,"share":"https://ttm.financial/m/news/2206351468?lang=en_US&edition=fundamental","pubTime":"2022-01-25 23:17","market":"us","language":"en","title":"3 Money Machine Stocks to Buy at 52-Week Lows","url":"https://stock-news.laohu8.com/highlight/detail?id=2206351468","media":"Motley Fool","summary":"These fintech businesses are raking in profits, but their stock prices have been tanking anyway.","content":"<div>\n<p>Did you miss out on the mega-dip of March 2020? Well, the market meltdown of early 2022 is giving investors another chance to buy heaps of stocks that once rocketed upwards at a deep discount.Of ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/25/3-money-machine-stocks-to-buy-at-52-week-lows/\">Source Link</a>\n\n</div>\n","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Money Machine Stocks to Buy at 52-Week Lows</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Money Machine Stocks to Buy at 52-Week Lows\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-25 23:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/25/3-money-machine-stocks-to-buy-at-52-week-lows/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Did you miss out on the mega-dip of March 2020? Well, the market meltdown of early 2022 is giving investors another chance to buy heaps of stocks that once rocketed upwards at a deep discount.Of ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/25/3-money-machine-stocks-to-buy-at-52-week-lows/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"COIN":"Coinbase Global, Inc.","BK4532":"文艺复兴科技持仓","BK4503":"景林资产持仓","BK4551":"寇图资本持仓","BK4554":"元宇宙及AR概念","BK4116":"互联网服务与基础架构","BK4566":"资本集团","SHOP":"Shopify Inc","BK4528":"SaaS概念","BK4524":"宅经济概念","BK4112":"金融交易所和数据","BK4539":"次新股","BK4548":"巴美列捷福持仓","BK4106":"数据处理与外包服务","BK4535":"淡马锡持仓"},"source_url":"https://www.fool.com/investing/2022/01/25/3-money-machine-stocks-to-buy-at-52-week-lows/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2206351468","content_text":"Did you miss out on the mega-dip of March 2020? Well, the market meltdown of early 2022 is giving investors another chance to buy heaps of stocks that once rocketed upwards at a deep discount.Of course, not every high-growth stock that fell down this year deserves to get back up, and many won't. Luckily there's an easy way to tell which stocks are most likely to bounce back. They're the ones with cash in the bank and the means to generate lots more.Shares of these three fintech stocks have been beaten down to prices we haven't seen in over a year. That's a little surprising when you consider how much cash they're generating. Here's how patient investors who buy these stocks now could come out miles ahead down the road.1. Coinbase GlobalCoinbase Global (NASDAQ:COIN) stock has lost nearly half its value since reaching a peak last November. Now that the stock is trading near a 52-week low, you can scoop up shares for just 4.3 times the amount of free cash flow generated over the past 12 months.Declining cryptocurrency prices generally translate into significantly less trading activity, but Bitcoin, Ethereum, and an endless array of altcoins aren't going to disappear any time soon. Coinbase Global pockets trading fees that could make a stockbroker blush, so it doesn't take a crypto trading frenzy like we saw last year to drive strong profits.Third-quarter transaction revenue plunged 44% from the previous quarter to $1.1 billion, but premium service subscription revenue jumped 41% to $145 million. Altogether, the company still reported an impressive $618 million in adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA).Coinbase Global is already raking in cash hand over fist as a trading platform for cryptocurrencies themselves. Before the end of the year, though, growth could accelerate with the planned launch of a marketplace for trading non-fungible tokens (NFTs).2. ShopifyNow that the consumer spending boom brought about by the lockdown period of the pandemic has faded, Shopify (NYSE:SHOP) stock has tumbled to a 52-week low. Shares of the e-commerce giant are down by nearly half since the peak they reached last November despite being strongly profitable. Shopify reported an impressive $458 million in free cash flow over the past year.Shopify's recently depressed price looks like a terrific buying opportunity for patient investors. That's because it's going to take a lot more than a temporary consumer trend to stop this cash cow from delivering more profits down the road.At its heart, Shopify helps small business owners compete with their larger rivals. That usually includes helping businesses convert social media engagement into new product sales. Shopify's biggest draw, though, is a giant logistics network that enables much better fulfillment services than Shopify's clients could hope to provide by themselves. Even a sole proprietor just starting out with a new retail business can tap into Shopify's network of warehouses, which is rivaled only by Amazon and a few big box stores.In addition to your cousin's homemade candle shop, Shopify partners with some of the world's most recognizable brands, including Heineken, Logitech, and Hallmark. Making itself an indispensable partner for businesses large and small helped top-line revenue soar 46% year over year in the third quarter to $1.1 billion. With a relatively untapped network of entrepreneurs outside of the U.S. and an important partnership with Global-E Online to bring them into the fold, the company has everything it needs to keep producing impressive gains for many years to come.3. BlockBlock (NYSE:SQ) is another high-growth stock that's been tumbling despite strong cash flows from operations. Shares of this money machine soared in 2020 and early 2021, but the party didn't last. The troubled fintech stock has lost more than 60% of its value since it peaked last summer, despite reporting $794 million in cash from operations over the past 12 months.Buying shares of Block is a great way for investors to keep a finger on the pulse of blockchain-based innovation without owning any specific currency directly. Block's payment processing business, Cash App, began allowing its users to trade Bitcoin in 2017. In order to facilitate transactions, the company's been amassing Bitcoin itself and finished September with a Bitcoin investment that had a carrying value of $149 million.Market prices pushed the fair value of Block's Bitcoins up to $352 million last September. While Bitcoin's previous gains have mostly been wiped out, Block's still in a position to complete heaps of blockchain-based transactions for everyday goods and services.At recent prices, you can buy Block shares for just 2.6 times forward sales expectations, which is awfully cheap for a company growing this fast. The company processed a whopping $45.4 billion worth of payments in the third quarter, which was 43% more than it processed a year earlier.","news_type":1,"symbols_score_info":{"COIN":1,"SQ":1,"SHOP":1}},"isVote":1,"tweetType":1,"viewCount":1581,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9935612814,"gmtCreate":1663080252838,"gmtModify":1676537198776,"author":{"id":"4090372448888540","authorId":"4090372448888540","name":"winfredcth","avatar":"https://static.tigerbbs.com/c465570918f25ab6c6a51f818aeceaf0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090372448888540","authorIdStr":"4090372448888540"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9935612814","repostId":"1127934010","repostType":4,"repost":{"id":"1127934010","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1663078318,"share":"https://ttm.financial/m/news/1127934010?lang=en_US&edition=fundamental","pubTime":"2022-09-13 22:11","market":"us","language":"en","title":"Peloton Shares Plunged over 9% as Chairman Exits in Shake-Up","url":"https://stock-news.laohu8.com/highlight/detail?id=1127934010","media":"Tiger Newspress","summary":"Peloton shares plunged over 9% as chairman exits in shake-up. Peloton co-founder John Foley and othe","content":"<html><head></head><body><p>Peloton shares plunged over 9% as chairman exits in shake-up. Peloton co-founder John Foley and other senior leaders are leaving the company in a management shake-up as the maker of connected exercise equipment races to turn itself around.<img src=\"https://static.tigerbbs.com/59406f646cb326d6b842b73c686354a5\" tg-width=\"830\" tg-height=\"826\" width=\"100%\" height=\"auto\"/>Peloton has struggled with deepening losses this year after a pandemic-fueled spike in demand for its at-home workouts left the company with a glut of unsold bicycles when consumers returned to gyms and outdoor activities. The company’s shares have plunged more than 90% over the past year.</p><p>Mr. Foley, who led the company for most of its 10-year existence,stepped down as CEOin February but remained executive chairman of the board. He resigned on Monday, the company said, and will be succeeded as board chair byKaren Boone, a former executive at Restoration Hardware and a Peloton board member since 2019.</p><p>The shake-up, announced by Chief Executive Barry McCarthy, comes weeks after Peloton reported a $1.2 billion quarterly loss and a nearly 30% drop in revenue. Mr. McCarthywarned investors in Augustthat the business would likely spend more cash than it brings in for several more months.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Peloton Shares Plunged over 9% as Chairman Exits in Shake-Up</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPeloton Shares Plunged over 9% as Chairman Exits in Shake-Up\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-09-13 22:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Peloton shares plunged over 9% as chairman exits in shake-up. Peloton co-founder John Foley and other senior leaders are leaving the company in a management shake-up as the maker of connected exercise equipment races to turn itself around.<img src=\"https://static.tigerbbs.com/59406f646cb326d6b842b73c686354a5\" tg-width=\"830\" tg-height=\"826\" width=\"100%\" height=\"auto\"/>Peloton has struggled with deepening losses this year after a pandemic-fueled spike in demand for its at-home workouts left the company with a glut of unsold bicycles when consumers returned to gyms and outdoor activities. The company’s shares have plunged more than 90% over the past year.</p><p>Mr. Foley, who led the company for most of its 10-year existence,stepped down as CEOin February but remained executive chairman of the board. He resigned on Monday, the company said, and will be succeeded as board chair byKaren Boone, a former executive at Restoration Hardware and a Peloton board member since 2019.</p><p>The shake-up, announced by Chief Executive Barry McCarthy, comes weeks after Peloton reported a $1.2 billion quarterly loss and a nearly 30% drop in revenue. Mr. McCarthywarned investors in Augustthat the business would likely spend more cash than it brings in for several more months.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PTON":"Peloton Interactive, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1127934010","content_text":"Peloton shares plunged over 9% as chairman exits in shake-up. Peloton co-founder John Foley and other senior leaders are leaving the company in a management shake-up as the maker of connected exercise equipment races to turn itself around.Peloton has struggled with deepening losses this year after a pandemic-fueled spike in demand for its at-home workouts left the company with a glut of unsold bicycles when consumers returned to gyms and outdoor activities. The company’s shares have plunged more than 90% over the past year.Mr. Foley, who led the company for most of its 10-year existence,stepped down as CEOin February but remained executive chairman of the board. He resigned on Monday, the company said, and will be succeeded as board chair byKaren Boone, a former executive at Restoration Hardware and a Peloton board member since 2019.The shake-up, announced by Chief Executive Barry McCarthy, comes weeks after Peloton reported a $1.2 billion quarterly loss and a nearly 30% drop in revenue. Mr. McCarthywarned investors in Augustthat the business would likely spend more cash than it brings in for several more months.","news_type":1,"symbols_score_info":{"PTON":0.9}},"isVote":1,"tweetType":1,"viewCount":4077,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006151177,"gmtCreate":1641655272140,"gmtModify":1676533637569,"author":{"id":"4090372448888540","authorId":"4090372448888540","name":"winfredcth","avatar":"https://static.tigerbbs.com/c465570918f25ab6c6a51f818aeceaf0","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090372448888540","authorIdStr":"4090372448888540"},"themes":[],"htmlText":"Yes","listText":"Yes","text":"Yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006151177","repostId":"1134509683","repostType":4,"repost":{"id":"1134509683","kind":"news","pubTimestamp":1641612579,"share":"https://ttm.financial/m/news/1134509683?lang=en_US&edition=fundamental","pubTime":"2022-01-08 11:29","market":"us","language":"en","title":"3 COVID Stocks That Will Make Billions in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=1134509683","media":"Motley Fool","summary":"These three COVID-19 stocks could rake in a tremendous amount of cash this year.","content":"<html><head></head><body><p>It&#39;s a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to make billions of dollars in 2022. Here are three stocks that should thrive.</p><p><b>Pfizer</b>(NYSE:PFE), the $310 billion mega cap, is expected to bring in not $1 billion or $10 billion but over $50 billion in sales for its COVID vaccine and antiviral pill. Scrappy <b>Novavax</b>(NASDAQ:NVAX)is finally introducing its COVID vaccine around the world. How many billions will it receive? And we have a dark horse candidate in <b>Vir Biotechnology</b>(NASDAQ:VIR). It has a drug that could easily be a $1 billion blockbuster for the tiny biotech.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/488a166201699c1f3d6536aa3e640ecf\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"/><span>IMAGE SOURCE: GETTY IMAGES.</span></p><p><b>A safe harbor in stormy weather</b></p><p><b>George Budwell(Pfizer):</b>Pfizer is the undisputed champion of COVID-19 pharmaceutical products. In 2022 alone, Wall Street expects the pharma giant to rake in $55 billion in sales between its novel coronavirus vaccine, Comirnaty, and its oral antiviral pill, Paxlovid.</p><p>What&#39;s more, analysts are starting to warm up to the idea that Paxlovid might be a sustainable revenue generator for the company over the course of the current decade. When the drug was first allowed on the market by the Food and Drug Administration under the Emergency Use Authorization pathway last month, Wall Street thought Paxlovid would likely peak from a commercial standpoint within a year or so, and then experience a dramatic drop in sales as the pandemic faded from view.</p><p>But less than three weeks out from the drug&#39;s initial approval, it is becoming painfully obvious that Paxlovid will probably be required as a fail-safe against the worst outcomes from COVID-19 for several more years. The highly infectious omicron variant, after all, will certainly not be the last major iteration of the virus.</p><p>What this all means is that Pfizer ought to be one of the few large-cap drugmakers with a sizable, long-term COVID-19 revenue source. Pfizer, in turn, should have ample free cash flows to feed its generous shareholder reward program, as well as its ambitious business development plans, for the foreseeable future.</p><p>So, if you&#39;re looking for a stock that can weather the dual headwinds of sky-high inflation and rising interest rates, Pfizer might be worth checking out.</p><p><b>Revenue forecasts for Novavax:  $2 billion to $8 billion</b></p><p><b>Taylor Carmichael(Novavax):</b>Novavax is on the verge of greatness this year. The company&#39;s stock price is down to $125 a share. That&#39;s where it started in 2021, so last year was pretty much a washout for the stock.</p><p>Back in February the share price zoomed over $300 when Novavax reported positive phase 3 data for its COVID vaccine. But then the small biotech ran into manufacturing issues. While its vaccine is said by many to be the best in class, scaling up the contract manufacturing for an estimated 2 billion doses of vaccine is easier said than done. And those realities have caused the stock to drop about 60% off its highs.</p><p>Nonetheless, Novavax has already hit the $1 billion revenue mark, so its vaccine was a blockbuster even before it was approved, because of all the preorders. Now that authorizations are pouring in from around the globe, it&#39;s highly likely that Novavax will ship a massive number of vaccine doses in 2022. The company&#39;s already achieved a manufacturing capacity of 100 million doses a month, or 1.2 billion doses in a year. On the third-quarter earnings call, management predicted it would reach a manufacturing capacity of 150 million doses every month (or 1.8 billion doses a year) by the end of the fourth quarter. And the company expects to continue to scale and forecasts that it will distribute 2 billion doses in 2022.</p><p>Two billion doses of vaccine, at a price point of $16 (Operation Warp Speed paid $1.6 billion to pre-order 100 million doses) gives us a back-of-the-envelope calculation of $32 billion in revenue. Of course, Novavax will be distributing a lot of vaccines to the developing world at a reduced rate. While the company has been quiet about its prices, Denmark said back in August that it paid almost $21 a dose under the European Union (EU) agreement. The EU has ordered 200 million doses, so that&#39;s over $4 billion in sales, just in Europe.</p><p>Analysts are being extremely conservative, with a forecast ranging from $2 billion to $8 billion for Novavax in 2022. (The company&#39;s market cap sits at $9 billion.) While there may be hiccups along the way, Novavax is sure to make billions of dollars off its COVID-19 vaccine in 2022. And there could be significant upside to the stock if the company does indeed deliver 2 billion doses as it says it will.</p><p><b>The antibody market all to itself</b></p><p><b>Patrick Bafuma(Vir Biotechnology):</b>The omicron variant is currently running rampant, and this time, we are short a few treatments. Previously favored monoclonal antibody treatments from <b>Eli Lilly</b> (bamlanivimab plus etesevimab) as well as the REGEN-COV cocktail from <b>Roche</b>and<b>Regeneron</b> are believed to have marked diminished activity against the current variant. This leaves a single infusiont hought to be active against omicron--<b>GlaxoSmithKline</b> and Vir Biotechnology&#39;s sotrovimab. This monoclonal antibody previously demonstrated a reduced risk of hospitalization and death by 79% in adults with mild to moderate COVID-19 and at high risk of progression to severe disease. And it&#39;s the only one left right now to fight the omicron variant.</p><p>Being the sole monoclonal antibody on the block will have its privileges. Through the first nine months of 2021, REGEN-COV brought in $3.5 billion in net product sales, while Eli Lilly&#39;s antibody combination brought in $1.17 billion. The U.S. government has already contracted for approximately $1 billion worth of sotrovimab. With hospitals overflowing with patients, anything that can help alleviate some of the stress on the system is likely going to be highly sought after.</p><p>And while Pfizer&#39;s Paxlovid will be hugely beneficial to ease the COVID-19 burden on the healthcare system, the oral medication has significant and complex drug-drug interaction potential. In fact, its interaction list reads like a who&#39;s who of commonly prescribed medications. This includes popular blood thinning agents such as Plavix and Xarelto, common analgesics like Tramadol and oxycodone, anxiolytics like Klonopin and Xanax, as well as cholesterol-fighting statins. With the National Institutes of Health issuing a statement voicing its concern over Paxlovid&#39;s possible drug interactions, this leaves plenty of room for sotrovimab to continue to be widely prescribed. With Vir getting 72.5% of sotrovimab sales per its agreement with GSK, the $4.4 billion biotech looks like a bargain right now.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 COVID Stocks That Will Make Billions in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 COVID Stocks That Will Make Billions in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-08 11:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It's a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞","VIR":"Vir Biotechnology, Inc."},"source_url":"https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134509683","content_text":"It's a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to make billions of dollars in 2022. Here are three stocks that should thrive.Pfizer(NYSE:PFE), the $310 billion mega cap, is expected to bring in not $1 billion or $10 billion but over $50 billion in sales for its COVID vaccine and antiviral pill. Scrappy Novavax(NASDAQ:NVAX)is finally introducing its COVID vaccine around the world. How many billions will it receive? And we have a dark horse candidate in Vir Biotechnology(NASDAQ:VIR). It has a drug that could easily be a $1 billion blockbuster for the tiny biotech.IMAGE SOURCE: GETTY IMAGES.A safe harbor in stormy weatherGeorge Budwell(Pfizer):Pfizer is the undisputed champion of COVID-19 pharmaceutical products. In 2022 alone, Wall Street expects the pharma giant to rake in $55 billion in sales between its novel coronavirus vaccine, Comirnaty, and its oral antiviral pill, Paxlovid.What's more, analysts are starting to warm up to the idea that Paxlovid might be a sustainable revenue generator for the company over the course of the current decade. When the drug was first allowed on the market by the Food and Drug Administration under the Emergency Use Authorization pathway last month, Wall Street thought Paxlovid would likely peak from a commercial standpoint within a year or so, and then experience a dramatic drop in sales as the pandemic faded from view.But less than three weeks out from the drug's initial approval, it is becoming painfully obvious that Paxlovid will probably be required as a fail-safe against the worst outcomes from COVID-19 for several more years. The highly infectious omicron variant, after all, will certainly not be the last major iteration of the virus.What this all means is that Pfizer ought to be one of the few large-cap drugmakers with a sizable, long-term COVID-19 revenue source. Pfizer, in turn, should have ample free cash flows to feed its generous shareholder reward program, as well as its ambitious business development plans, for the foreseeable future.So, if you're looking for a stock that can weather the dual headwinds of sky-high inflation and rising interest rates, Pfizer might be worth checking out.Revenue forecasts for Novavax:  $2 billion to $8 billionTaylor Carmichael(Novavax):Novavax is on the verge of greatness this year. The company's stock price is down to $125 a share. That's where it started in 2021, so last year was pretty much a washout for the stock.Back in February the share price zoomed over $300 when Novavax reported positive phase 3 data for its COVID vaccine. But then the small biotech ran into manufacturing issues. While its vaccine is said by many to be the best in class, scaling up the contract manufacturing for an estimated 2 billion doses of vaccine is easier said than done. And those realities have caused the stock to drop about 60% off its highs.Nonetheless, Novavax has already hit the $1 billion revenue mark, so its vaccine was a blockbuster even before it was approved, because of all the preorders. Now that authorizations are pouring in from around the globe, it's highly likely that Novavax will ship a massive number of vaccine doses in 2022. The company's already achieved a manufacturing capacity of 100 million doses a month, or 1.2 billion doses in a year. On the third-quarter earnings call, management predicted it would reach a manufacturing capacity of 150 million doses every month (or 1.8 billion doses a year) by the end of the fourth quarter. And the company expects to continue to scale and forecasts that it will distribute 2 billion doses in 2022.Two billion doses of vaccine, at a price point of $16 (Operation Warp Speed paid $1.6 billion to pre-order 100 million doses) gives us a back-of-the-envelope calculation of $32 billion in revenue. Of course, Novavax will be distributing a lot of vaccines to the developing world at a reduced rate. While the company has been quiet about its prices, Denmark said back in August that it paid almost $21 a dose under the European Union (EU) agreement. The EU has ordered 200 million doses, so that's over $4 billion in sales, just in Europe.Analysts are being extremely conservative, with a forecast ranging from $2 billion to $8 billion for Novavax in 2022. (The company's market cap sits at $9 billion.) While there may be hiccups along the way, Novavax is sure to make billions of dollars off its COVID-19 vaccine in 2022. And there could be significant upside to the stock if the company does indeed deliver 2 billion doses as it says it will.The antibody market all to itselfPatrick Bafuma(Vir Biotechnology):The omicron variant is currently running rampant, and this time, we are short a few treatments. Previously favored monoclonal antibody treatments from Eli Lilly (bamlanivimab plus etesevimab) as well as the REGEN-COV cocktail from RocheandRegeneron are believed to have marked diminished activity against the current variant. This leaves a single infusiont hought to be active against omicron--GlaxoSmithKline and Vir Biotechnology's sotrovimab. This monoclonal antibody previously demonstrated a reduced risk of hospitalization and death by 79% in adults with mild to moderate COVID-19 and at high risk of progression to severe disease. And it's the only one left right now to fight the omicron variant.Being the sole monoclonal antibody on the block will have its privileges. Through the first nine months of 2021, REGEN-COV brought in $3.5 billion in net product sales, while Eli Lilly's antibody combination brought in $1.17 billion. The U.S. government has already contracted for approximately $1 billion worth of sotrovimab. With hospitals overflowing with patients, anything that can help alleviate some of the stress on the system is likely going to be highly sought after.And while Pfizer's Paxlovid will be hugely beneficial to ease the COVID-19 burden on the healthcare system, the oral medication has significant and complex drug-drug interaction potential. In fact, its interaction list reads like a who's who of commonly prescribed medications. This includes popular blood thinning agents such as Plavix and Xarelto, common analgesics like Tramadol and oxycodone, anxiolytics like Klonopin and Xanax, as well as cholesterol-fighting statins. With the National Institutes of Health issuing a statement voicing its concern over Paxlovid's possible drug interactions, this leaves plenty of room for sotrovimab to continue to be widely prescribed. With Vir getting 72.5% of sotrovimab sales per its agreement with GSK, the $4.4 billion biotech looks like a bargain right now.","news_type":1,"symbols_score_info":{"NVAX":0.9,"VIR":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":1340,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}